Final Results

Released : 13 Jun 2013

RNS Number : 9221G
Halma PLC
13 June 2013
 



HALMA plc

 

PRELIMINARY STATEMENT FOR THE 52 WEEKS TO 30 MARCH 2013

 

13 JUNE 2013

 

Record results and continued dividend growth

 

 

 

Halma, the leading safety, health and environmental technology group, today announces its preliminary statement for the 52 weeks to 30 March 2013.

 

 

 

Financial Highlights


2013

2012

Change

Continuing Operations:




Revenue

£619.2m

£579.9m

+7%

Adjusted Profit before Taxation1

£130.7m

£120.5m

+8%

Statutory Profit before Taxation

£122.3m

£112.0m

+9%





Adjusted Earnings per Share2

26.22p

24.46p

+7%

Statutory Earnings per Share

25.22p

23.01p

+10%

Total Dividend per Share3

10.43p

9.74p

+7%





Return on Sales4

21.1%

20.8%


Return on Total Invested Capital5

15.8%

16.8%


Return on Capital Employed5

71.3%

74.7%


 

 

 

 

 

Adjusted pre-tax profit from continuing operations1 up 8% to £130.7m (2012: £120.5m) on revenue up 7% at £619.2m (2012: £579.9m). Return on Sales4 of 21.1% (2012: 20.8%).

 

 

 

Organic growth5 at constant currency: Profit up 5%, Revenue up 3%.

 

US and China revenue up strongly; UK and Mainland Europe revenue lower. 

 

Strong performances in Medical and Process Safety sectors; solid progress in Infrastructure Safety; slightly lower profit in Environmental & Analysis.

 

Order intake ahead of revenue in the second half and order books increased across all sectors.

  

 

 

Adjusted earnings per share from continuing operations2 up 7% to 26.22p (2012: 24.46p). Statutory earnings per share up 10% to 25.22p (2012: 23.01p).

 

Six acquisitions and one disposal completed. Acquisition pipeline remains healthy.

 

Good cash flow maintained. Net debt of £110.3m at period end (2012: £18.7m). Borrowing facilities of £260m in place until 2016, providing significant financial capacity for investment in organic growth and value adding acquisitions.

 

Final dividend of 6.37p per share, representing a 7% increase in total dividend to 10.43p per share for the year (2012: 9.74p) marking the Group's 34th consecutive year of dividend increases of 5% or more.

 

 

 

Andrew Williams, Chief Executive of Halma, commented:

"During the past year, we have continued to strengthen our business by further increasing investment in our drivers of organic growth - innovation, people development and international expansion.  We have significantly improved the fundamental quality of our portfolio through six acquisitions and one disposal.

 

Order intake since the start of 2013 has been consistent with our expectations of sustaining year-on-year organic growth and high returns.  We remain confident that Halma will make further progress in the year ahead."

 

 

 

Notes:

(1)

Adjusted to remove the amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration and profit on disposal of operations of £8.4m (2012: £8.5m). See note 2 to the Preliminary Statement.

 

(2)

Adjusted to remove the amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration, profit on disposal of operations and the associated tax. See note 6 to the Preliminary Statement.

 

(3)

Total dividend paid and proposed per share.

 

 

(4)

Return on Sales is defined as adjusted1 profit before taxation from continuing operations expressed as a percentage of revenue from continuing operations.

 

(5)

Organic growth rates, Return on Total Invested Capital and Return on Capital Employed are non-GAAP performance measures used by management in measuring the returns achieved from the Group's asset base.  See note 11 to the Preliminary Statement. 

 

 

 

 

For further information, please contact:

 


Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

+44 (0)1494 721111

MHP Communications
Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

 

 

NOTE TO EDITORS

 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 


●  Process Safety

Products which protect assets and people at work.

 


●  Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 


●  Medical

Products used to improve personal and public health.

 


●  Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 


The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential.  Many Group businesses are market leaders in their specialist field.

 

2.

High resolution photos of Halma senior management, including Chief Executive Andrew Williams, and images illustrating Halma business activities can be downloaded from its website: www.halma.com.  Click on the 'News' link, then 'Image Library'.  Photo queries:  David Waller +44 (0)1494 721111, e-mail: dwaller@halmapr.com.

 

3.

You can view or download copies of this announcement and the latest Half Year and Annual Reports from the website at www.halma.com or request free printed copies by contacting halma@halma.com.

 

4.

A copy of the Annual Report and Accounts will be made available to shareholders on 25 June 2013 either by post or online at www.halma.com and will be available to the general public online or on written request to the Company's registered office at Misbourne Court, Rectory Way, Amersham, Bucks HP7 0DE, UK.

 

5.

This announcement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

 

 

 

 

Chairman's Statement

 

A glance backwards and a glimpse forwards

As previously announced, I will be stepping down from the Board immediately after the AGM on 25 July 2013. Halma has only had two Chairmen in the past 40 years, the founder, David Barber, and myself. When David stepped down in July 2003 he departed from the annual reporting format of commenting on the year's results and instead reflected on some of Halma's achievements over the years. I thought I would do the same, as the results are reported fully elsewhere in this report, save to say that 2012/13 was another record year and we are recommending a dividend increase of 7%, the 34th year of increases of 5% or more.

 

"Welcome to Halma Mr Unwin"

My first AGM was in July 2003 and what immediately struck me was the number of private shareholders who were there - all passionate Halma followers. One gentleman came up to me and said, "I have been a loyal shareholder for many years and thanks to the progressive dividends from Halma, have been able to educate my children. So thank you, welcome to Halma Mr Unwin". He then fixed me with a look that said "and don't mess it up" (it may have been stronger!). It then really struck home what a privileged and onerous responsibility I had taken on.

 

Glancing back

So what has changed over the ten years?

 

Firstly, what has not changed is the fundamental business model: our companies operate in niche markets where demand is underpinned by strong growth drivers. They produce high returns on sales and capital, and those returns go to pay taxes, dividends and re-investment in the business, including buying more companies with similar characteristics. All this is embraced by strong reporting and controls.

 

One significant change was the appointment of Andrew Williams as CEO in February 2005, only the third CEO in Halma's history. Andrew provides clear, calm, insightful leadership and the Group's performance under his tenure speaks for itself. He is a pleasure to work with.

 

Our strategy has been sharpened, and the framework under which we operate more clearly defined (as set out in the Annual Report).

 

Delegation and strong autonomy has been re-enforced at the subsidiary company level. Our Managing Directors have huge freedom to operate and to innovate in response to what their customers are telling them. This freedom also generates high job satisfaction.

 

The necessary financial and management resources have been put in place to support our strategy. Two examples illustrate this.

 

·      Acquisitions: our Divisional Chief Executives (DCEs) are tasked with identifying suitable acquisitions. The pressure on their time was such that we found we were not seeing sufficient opportunities and when we decided 'to put money to work' we could not always reach our goals. So, we strengthened our acquisition sourcing efforts with a few highly experienced executives to support the DCEs. Our recent acquisition history illustrates that this is working effectively but, there will continue to be times when we decide that the economic climate or prices are not favourable and therefore we will stand aside for a while.

 

·      Geographic expansion: we recognised that we were underweight in the faster growing economies and unless addressed, our growth would suffer. The problem was how to make it easier for our companies to enter those markets? Our solution was to create hubs in China and India (with other sector-based hubs now following) staffed by people with the remit to do whatever was necessary to make it easier for our companies to start operating there. One can see a logical progression of our business in, say, China. We start with a hub, then increase local sales through our regional offices, then local product assembly, then local R&D. As a result more MDs are resident in the region and finally we start to acquire companies, e.g. Longer Pump acquired this year in China. In 2003 under 10% of our business came from Asia Pacific, this year it is over 16% and in China our headcount has moved from 70 to 770. We have made a significant investment and the foundations are strong for growth in the future.

 

Incentives. At the beginning of the period, bonuses were rarely achieved and options were under-water. We refreshed the total remuneration framework based around Economic Value Added (EVA) together with introducing new long-term incentives all aligned with our strategy and adding shareholder value. Shareholders can see very clearly that in very good years bonuses will hit their maximum and in poor years may well be zero. They correlate. No surprises there, they are based on EVA. It was also flattering to hear that one of our major shareholders cites the Halma remuneration scheme as a model for others!

 

Much emphasis has also been placed on the quality of our company boards, particularly against the ever-increasing demands of global markets. Formal management training has been introduced tailored to our needs. This started with the Halma Executive Development Programme and now runs right through to our own graduate development programme. This has also encouraged our companies to develop training programmes of their own.

 

We have taken steps on gender diversity at the Board level, although at the company level it is much more difficult unless more female talent is encouraged throughout our operations. Pleasingly, in 2013, the majority of our graduate programme recruits are female.

 

A number of promotions have come from within so that people can see career opportunities across the Group - not just their own company.

 

There has been a major shift in sharing and co-operation, helped by our training programmes and using technology (intranets and social media) to enable it. We introduced a Halma Innovation and Technology Exposition four years ago, which is now held every two years to enable all the companies to share their innovation and technology with other Halma companies. This event has become more and more powerful and effective; there is a palpable buzz in the air.

 

In the period since March 2003 we have increased our dividend per share by 79% declaring £300m of dividends for shareholders. Halma's market capitalisation has increased nearly five-fold and we have become one of the top 150 companies on the London Stock Exchange.

 

A glimpse forwards

·   The basic model is sound and our strategy, which is kept under challenging review, will evolve, just as it has done over the years.

 

·   More and more of our subsidiary boards will have to deal with the challenge of moving from domestic, single continent operations to global, multi-continent operations. As we know, this is not a trivial matter and the model that works best for each company will largely be dictated by the structure of their customers.

 

·   To compete we have to have the best teams, so training, development and talent spotting will continue to increase in importance.

 

·   2016 or thereabouts will be a key year; the year when China is forecast to overtake the USA as the world's biggest economy (according to the OECD after accounting for price differences). This will have a profound effect. For Halma, it means that the centre of gravity of R&D will change, and that's only three years ahead!

 

·   These changes will test our structures, but I know Halma will rise to these challenges.

 

·   Progress up the FTSE also brings new pressures. More and more people will be aware of Halma.

 

·   Finally, for sure, the pace of business and innovation will not get any slower. I used to say in a previous life, that what used to take us nine months to achieve would shortly be required in nine weeks and then, who knows, nine days!

 

I hope this gives some insight into the way Halma has evolved over the last ten years and gives a glimpse to the future.

 

What is certain is that these changes, and the performance over these years is due to a truly dedicated team of people across the Group. It is their focus on our customers and the markets they serve that make the difference. To everyone in Halma, I say a sincere thank you for all that you have achieved, you have made my role a pleasure.

 

I should also like to thank my predecessor, David Barber, for making my induction into the Company he founded so smooth; to all my colleagues on the Board, they have been terrific, both challenging and supportive as needed.

 

Finally, in Paul Walker, we have a highly successful international businessman with the relevant experience and the right personal attributes to chair Halma to even greater heights. I look forward to you welcoming him at the AGM.

 

It has been a privilege.

 

Geoff Unwin, Chairman

 

 

 

 

Strategic Review

 

Halma made good progress during the year delivering a strong trading performance, significant M&A activity and further increases in investment in geographic expansion, innovation and people development. Our four new reporting sectors, announced earlier this year, are clearly aligned with our long-term market growth drivers yet offer the potential for Halma to enter new, adjacent market niches within each sector. Halma's record of sustaining short-term financial success while investing to develop opportunities for the longer term gives us confidence for the future.

 

Record revenue and profit for the tenth consecutive year

Full year revenue increased by 7% to £619.2m (2012: £579.9m). Organic growth was 2% and 3% at constant currency. Full year adjusted1 profit increased by 8% to £130.7m (2012: £120.5m) with organic growth of 4% which was 5% at constant currency.

 

Excluding businesses sold during the current and prior years, revenue grew by 9% and profit was up by 10%.

 

We maintained steady growth momentum throughout the year. Order intake in the second half remained slightly ahead of revenue enabling us to make a positive start to the 2013/14 financial year.

 

Excellent returns and cash generation

We continued to achieve high returns with Return on Sales improving further to 21.1% (2012: 20.8%). Return on Capital Employed at the operating level remained high at 71.3% (2012: 74.7%) while our post-tax Return on Total Invested Capital was 15.8% (2012: 16.8%).

 

Cash generation was in line with expectations and we ended the period with net debt of £110m (2012: £19m) having spent £148m (2012: £20m) on acquisitions, £15.5m on capital expenditure (2012: £16.5m) and paid out £37.8m and £25.5m on dividends and tax respectively.

 

Strong growth in Asia, steady progress in USA and Europe

The relative trading patterns across the major global regions were consistent through the year. Growth from Asia Pacific of 15% was strong, with revenue exceeding £100m for the first time (2012: £87m). In aggregate, revenue from outside our traditional 'home' markets of the UK, Mainland Europe and USA grew by 14% to £157m (2012: £138m), now representing 25% of the Group and maintaining progress towards our target of 30% by 2015.

 

In total, revenue from the UK, Mainland Europe and USA increased by 5%. Revenue from the USA increased 20% to £195m (2012: £162m) boosted by recent acquisitions and organic growth (constant currency) of 4%. Trading conditions were tougher in the UK and Mainland Europe. In the UK, revenue decreased by 8% to £116m (2012: £126m) although excluding the impact of disposals, the organic decline at constant currency was only 3%. Revenue from Mainland Europe was 2% lower at £152m (2012: £154m) although, here again, the organic decline in constant currency terms was lower, at just 0.5%.  

 

New reporting sectors

For the first time Halma's results are reported under four sectors which are clearly aligned with our core markets of safety, health and environmental. Full details of the background to this change were released in our announcement on 14 February 2013 and can be seen on our website www.halma.com.

 

Process Safety performed strongly with revenue up by 3% to £125.7m (2012: £122.2m) and profit2 increasing by 11% to £32.3m (2012: £29.2m). Excluding the contribution of Tritech, which was sold in August 2012, continuing operations revenue grew by 10% and profit by 16%. Organic revenue growth at constant currency was 10% with continued strong demand from energy and resources markets. Together with process industries these markets contribute around 60% of sector revenue and benefit from increasing Health and Safety regulation.

 

Return on Sales increased from 23.9% to 25.7% through a combination of strong revenue growth and gross margins supported by continuous improvement in new product innovation.

 

Organic revenue growth at constant currency for markets outside the UK, Mainland Europe and USA was an impressive 29% resulting in these fast developing markets now representing 28% of the sector. Encouragingly, the performance in our traditional 'home' markets was robust with mid-single digit organic revenue growth at constant currency in Mainland Europe and USA and flat UK organic growth.

 

Infrastructure Safety delivered another solid year. Revenue increased 1% to £205.3m (2012: £204.3m) and profit2 grew by 7% to £41.8m (2012: £39.1m). Return on Sales improved from 19.1% to 20.3% with a significant factor being the improved profitability following the reorganisation of our companies selling elevator products. Organic revenue growth at constant currency was 1% which, following a flat first half, reflected a slight improvement during the second half. This resilience in demand comes from our focus on safety-critical product niches for regulated non-residential applications. Approximately two-thirds of sector revenue is installed in existing infrastructure rather than new construction.

 

New product introductions and increased investment in sales resources contributed to strong growth in the USA where organic revenue growth (constant currency) was 18%.  Elsewhere we saw modest rates of growth in the UK and Asia Pacific while, unsurprisingly, almost every business in this sector experienced difficult conditions in Mainland Europe, resulting in organic revenue decline there of 8%.

 

Medical had an outstanding year, increasing revenue by 36% to £136.1m (2012: £100.4m) and profit2 by 37% to £35.9m (2012: £26.3m). Return on Sales increased further from 26.2% to 26.4%. The underlying organic revenue growth (constant currency) was 12%. As expected, slowly improving demand for fluid control components from major medical OEM customers, steady growth in ophthalmology markets and our increased product innovation were the significant contributory factors to this excellent result.

 

Our strategic focus on small medical devices and components rather than high value capital equipment, enabled us to mitigate the negative impact from government austerity spending cuts in certain markets. The fundamental market drivers of an ageing population in the West and a growing and wealthier population in the East, give us continued confidence for the future.

 

Both the USA and Mainland Europe performed well with organic revenue growth (constant currency) of 12% and 17% respectively, whilst the UK saw organic revenue decline of 3%. Revenue from outside these three major territories increased organically by 12%, to now represent 25% of the sector. Our real exposure to these faster growing markets is greater, as a sizeable proportion of our revenue from the USA and Mainland Europe is to global OEMs who subsequently export their finished systems to other global regions.

 

Environmental & Analysis had a relatively disappointing year as revenue declined by 1% to £152.4m (2012: £153.4m) and profit2 reduced by 4% to £30.4m (2012: £31.6m). Return on Sales was 19.9% (2012: 20.6%). Organic revenue at constant currency was down 6%. Reduced government research spending in the USA and lower investment by water utilities in the UK were the two major adverse market factors.

 

These market factors are clearly reflected in the regional trends with organic revenue (constant currency) declines of 14% in the UK and 10% in the USA. Organic revenue from Mainland Europe fell by 4%. Our companies continue to invest in growth in markets outside the UK, Mainland Europe and USA with revenue from these developing markets being 27% of the total sector, contributing organic growth of 6%.

 

Despite the challenges faced by Environmental & Analysis in the past year, we are confident that the management and organisational changes currently being made will improve performance in the future. These include simplifying global sales channels and manufacturing operations together with increasing senior management resources to focus on accelerating growth in Asia and from recent new technology innovation. It is expected that the total cost of this reorganisation will be around £1m in 2013/14.

 

Six acquisitions and one disposal completed

During the year we spent £136.8m (2012: £13.3m) on acquisitions plus £15.8m (2012: £5.4m) contingent consideration on acquisitions made in previous years but excluding £4.6m (2012: (£1.1m)) of net cash/(debt) acquired.

 

We acquired Accutome, Sensorex and SunTech Medical Group in the first quarter of the financial year for a total initial consideration of US$108.6m (£68.7m). Full details of these transactions were included in our Annual Report and Accounts 2012. Since acquisition, these companies have continued to trade in line with our expectations with the vendors of SunTech receiving an earn-out payment of US$6m and Accutome's vendors expected to receive an estimated earn-out of US$5m for profit growth since joining Halma.

 

In December 2012, we acquired MicroSurgical Technologies (MST) for US$57.4m (£35.5m) plus an earn-out of up to US$43m (£26.6m) based on future profit growth. Based in Redmond, Washington, USA, the company designs and manufactures ophthalmic surgical products with a focus on single-use devices used in cataract surgery. MST's results are reported as part of Halma's Medical sector.

 

In January 2013, we acquired Baoding Longer Precision Pump Co (Longer Pump) for RMB242m (£24.3m). Longer Pump designs and manufactures its own range of precision pumps which are used in medical, laboratory and industrial applications, and is also part of Halma's Medical sector. The business is based in Baoding, close to Beijing and is Halma's largest ever stand-alone acquisition in China.

 

In March 2013, we acquired ASL Holdings for £6.4m and contingent consideration of up to £3.5m based on growth over the next two years. ASL designs and manufactures remote data monitoring solutions for a range of markets including utilities. It has become part of HWM-Water which is a global leader in datalogging and leak detection products for the water industry within Halma's Environmental & Analysis sector.

 

Following the year end, in April 2013, we acquired a small technology bolt-on for one of our Infrastructure Safety businesses, Fire Fighting Enterprises (FFE). Talentum, based in Oldham, UK was acquired for £2.6m and adds new flame detection products to FFE's existing range of fire optical beam smoke detectors.

 

We made one disposal during the year. In August 2012, we sold our single Asset Monitoring business, Tritech International, for £22m to Moog Components Group (Moog). We concluded that, despite the attractive aspects of Tritech's end markets, we could create greater shareholder value by reallocating resources to other Halma sector niches and that Moog's presence in the marine energy markets would enable Tritech to make stronger progress under their ownership. This disposal, along with the sale of Volumatic in March 2012, demonstrates the importance of Halma's ability to manage our portfolio in order to sustain financial success over the long term.

 

We are continuing to add new opportunities to our acquisition pipeline process in all four of our new reporting sectors. Although the past year has been productive, we are working to both integrate these newly acquired businesses and progress further opportunities into the later stages of our acquisition process. We remain confident in our ability to find and acquire high quality businesses within our chosen markets over the medium term.

 

Strategic growth priorities

We have a clear strategy to generate sustained organic growth, actively manage our portfolio and deliver increased dividends. The average medium-term rate of organic growth determines the rate at which we can acquire companies and increase dividends. Our management reward structures are clearly aligned with this objective of delivering sustained growth and high returns. We actively manage our business portfolio through acquiring in (or adjacent to) our existing markets, merging companies as market needs change and selling businesses where we do not see the medium-term prospects for sustaining high returns or growth.

 

We drive organic growth through a focus on investing in the three areas of: Innovation, People Development and International Expansion.

 

Innovation

Our businesses build market leadership, gain market share or create new market opportunities through innovation in products and processes. Within Halma, companies have great opportunities to collaborate and share know-how with their sister companies. We have created a culture and environment to encourage this behaviour in a variety of ways including ensuring a diverse mix of representation at Halma training programmes and holding a biennial Halma Innovation and Technology Exposition (HITE). Network groups and forums focused on specific functional areas such as manufacturing and IT have also been established to foster regular benchmarking and continuous improvement.

 

In early May 2013, we held our third HITE event in Florida, USA which included a two-day Halma 'trade-show' where all the Group's companies showcased their innovation and technologies to one another. HITE is a catalyst for collaboration between our businesses and is a visible example of how Halma's culture has changed, and continues to evolve. Collaboration and learning from each other is increasing the rate of innovation and, consequently, building competitive advantage in our chosen markets. We invited institutional investors and analysts to join us at HITE 2013 and, following their positive feedback, it is something that we will be keen to repeat at HITE 2015.

 

Innovation is formally recognised in Halma through the annual Halma Innovation Awards where the first prize for the winning employee(s) is £20,000.

 

The Halma Innovation Award 2013, was won by a team from Hanovia in Slough, UK who developed a new UV treatment system for ensuring water in the ballast tanks of ships can be discharged without the risk of invasive species contamination, in compliance with impending global regulations. The runners up were a team from Oseco in Oklahoma, USA who developed a bursting disk which gives market-leading performance for both gas and liquid applications. In third place was a team from BEA who developed the new IXIO dual technology door sensor which combines BEA's usual market-leading sensor performance with a multilingual LED graphical display, making it the 'easiest to install' product on the market.

 

Increased innovation in Halma is reflected in the greater investment which our companies are making in R&D. This year, R&D expenditure grew by over 13% to £31.1m (2012: £27.4m) with all four Halma sectors increasing R&D spend as a proportion of revenue. Our M&A activity over the past year has been supportive of this trend as has been our ability to increase R&D spend in those businesses we acquired in 2011/12.

 

People development

Halma's decentralised operating structure is successful on a sustainable basis because we continue to improve the quality of management across our business. We build and develop local management teams who thrive on the opportunity to make timely decisions for their business as customer needs dictate. R&D, manufacturing, sales and marketing, and financial control resources are managed by our subsidiary boards who have an intimate knowledge of their markets and are, therefore, best placed to make local resource allocation decisions quickly. Subsidiary company strategic objectives, annual performance goals and management incentives are aligned with Halma's and are underpinned with a relentless commitment to attract and develop high quality talent.

 

In support of local employee development initiatives, Halma offers a range of training for employees including the Halma Executive Development Programmes (HEDP and HEDP+), Halma Management Development Programmes (HMDP and HMDP+) and Halma Certificate in Applied Technology (HCAT) programmes. During 2012/13, 179 employees attended these Halma run programmes. In addition, senior executives are encouraged to attend external training programmes at top international business schools. In the last year, one of our Divisional Chief Executives completed the Global CEO Programme run by IESE Business School whilst another has just completed the Advanced Management Program at Harvard.

 

A highlight of the year was the successful launch of the first ever Halma Graduate Development Programme (HGDP). The initial group of nine graduates came from a mix of technical and geographic backgrounds and have done a fantastic job of making the most of the opportunities given to them as well as teaching us new ways to innovate and grow our business. The 2013 intake is another impressive group from top universities. Through HGDP, we aim to increase the depth of talent coming through our management ranks and also expect it to contribute to an increase in management diversity in the medium term. During HGDP, graduates work at Group companies in different global regions and attend residential training modules. Halma is an attractive employer for new graduates offering them the chance to work in diverse markets and to gain international experience in an organisation which is able to offer opportunities for significant early career progression.

 

International expansion

We choose to operate in niches within markets with robust, long-term growth drivers on a global scale. This gives our businesses the opportunity to sustain growth in all regions of the world.

 

Our strategic objective is for at least 30% of revenue to come from outside the UK, Mainland Europe and the USA by 2015 and this year we increased this proportion from 23.8% to 25.4%. The significant growth we have achieved since setting up the first Halma hubs in China (2006) and in India (2008) has almost all been organic so the recent acquisition of Longer Pump in China will add further momentum during 2013/14.

 

Progress in China was excellent with revenue up 25% to £37m (2012: £29.5m) compared with just £6.6m when our Halma hubs were established in 2006. Today, almost 800 of our 4,995 employees are based in China.

 

Although revenue of £12.7m from South America was in line with the prior year, it was very encouraging to see two separate groups of Halma companies from our Medical and Process Safety sectors creating shared trading companies in Brazil. This is a great example of how Halma companies are now collaborating to accelerate their expansion into new territories where, in this case, the local healthcare and energy markets offer exciting opportunities for growth.

 

Macro-economics, regulatory and competitive environment

With our focus on the supply of safety, health and environmental related products, Halma businesses are positioned in relatively non-cyclical markets that have clear, long-term growth prospects. Most of our markets are underpinned by regulatory drivers where most customer spending is non-discretionary. Our businesses benefit from strong market positions providing upgrade and replacement sales opportunities. These factors combine to create genuine resilience in tough economic conditions and enable us to achieve organic growth above prevailing market growth rates.

 

Against this backdrop, we can invest for the longer term with confidence. Our competitive environment is heavily influenced by global, regional and national product approvals or technical validations. Compliance with product regulations is a steadily increasing cost and technical challenge but our focus on this area enables us to build competitive advantage.

 

We are exposed to a very diverse range of niche markets, each with its own unique market dynamic. Our approach is to empower local management to respond to changing market conditions by developing their own strategy. More details are given in the sector reviews in this Preliminary Statement.

 

In the current macro-economic environment each of our businesses is experiencing very different challenges and opportunities according to their particular market and geographic exposure. In 2013/14, we expect the macro-economic and political circumstances in Europe to remain challenging whilst we expect the US economy to maintain a relatively low rate of steady growth. We believe that the broader socio-economic development of developing regions such as Asia and South America will continue to increase demand for a safer environment and greater access to healthcare and energy/water resources.

 

Our primary market growth drivers

Halma's strategy is to develop market positions with a horizon of ten years or more. Growth strategies within our individual operating businesses have three to five-year horizons.

 

The markets we select must have robust growth drivers with potential for organic growth above the underlying market or GDP growth.

 

All of our businesses are positioned in markets that are underpinned by at least one of the following growth drivers:

 

Increasing health and safety regulation

Throughout the world, governments are requiring employers to comply with increasingly strict laws and regulations to protect workers from workplace hazards. In parallel with government regulation, many multinational employers based in the developed world are extending health and safety practice to developing regions. This combination of increasing safety regulation and globalisation drives demand for our Process Safety and Infrastructure Safety products.

 

The human cost of workplace accidents is enormous. The economic impact of poor occupational safety and health practice is lost working time, compensation, interruption of production and medical expenses. These costs are estimated to be about 4% of annual world Gross Domestic Product.

 

The International Labour Organisation estimates that every day around 6,300 people die as a result of occupational accidents or work-related diseases - more than 2.3 million deaths per year. 317 million work accidents occur annually; many of these resulting in extended absences from work.

 

Occupational deaths and injuries occur disproportionately in developing countries, where a large proportion of the population work in hazardous industries. However, significant advances have been made in occupational safety over the past decade and the number of fatal accidents has fallen.

 

Increasing demand for healthcare

Three demographic trends support increasing worldwide demand for healthcare:

 

·      global population ageing

·      global population growth

·      rising incomes in the developing world.

 

Demand for healthcare services and health-related products drives growth in our Medical markets. An increase in focus on preventive medicine and rising rates of chronic diseases such as cancer, diabetes and hypertension are key trends. Advances in medical technology and new medical procedures also stimulate demand for new equipment.

 

The number of people aged 60 and over is increasing dramatically. In 2010 there were 759 million people in the world aged 60 and over; this is projected to rise to 2 billion by 2050. While the older population is growing worldwide, most of the increase is in the developing regions. The proportion of the world's older population living in less developed regions is forecast to rise from 65% in 2010 to about 80% by 2050.

 

The global healthcare market is estimated to be over 10% of global GDP and rose by 43% over the period 2005 to 2010. Spending on healthcare continues to grow rapidly throughout the developed world, particularly in the USA (which accounts for 40% of total global medical expenditure) where spending is projected to rise by over a third between 2011 and 2016. Population growth and rising incomes in the developing world are also strong drivers of healthcare demand. China's healthcare spending, for example, is forecast to grow from $357 billion in 2011 to $1 trillion in 2020.

 

Increasing demand for life critical resources

Rising energy consumption and water usage, the inevitable consequences of social and economic development, are driven by three key trends:

 

·      population growth

·      rising living standards

·      changing patterns of food consumption and agriculture.

 

Several of our Environmental & Analysis businesses are positioned to benefit from the global trend of rising demand for energy and water. In both developed and developing regions we see increasing competition for water resources between industries and economic sectors, and between national governments. The increasing value placed on water resources drives demand for our water conservation, treatment, monitoring and testing products.

 

Global water demand rises relentlessly, predicted to increase by 50% by 2025 in developing countries, and by 18% in developed countries. Both the quality and availability of clean water continues to decline. Eighty per cent of the world's population lives in areas with high levels of threat to water security.

 

Water is essential to oil, gas and coal production but, increasingly, also in irrigation of biofuel crops. Water needs for energy production are forecast to grow at twice the rate of energy demand. Global energy demand is expected to grow by more than one-third over the period to 2035; China, India and the Middle East will account for 60% of this increase.

 

Continued increases in global oil and gas capital expenditure, predicted to rise by about 16% from 2012 to 2013, drives demand for our Process Safety products.

 

Delivering corporate responsibility and sustainability

Our primary market growth drivers mean that Halma companies operate in markets in which their products contribute positively to the wider community. These market characteristics and our commitment to health and safety, the environment and people development are reflected in the values held by our employees and our operating culture. Legislative changes, particularly concerning the environment and bribery and corruption, have provided an opportunity to review and ensure that our procedures in these important areas are accessible, compliant and firmly embedded within our business.

 

We review our responsibility and sustainability reporting in accordance with best practice. A detailed report on Corporate Responsibility is set out in the Annual Report and Accounts.

 

Change of Chairman

In July 2013, Geoff Unwin will step down as Chairman of Halma and I would like to take this opportunity to thank Geoff for the tremendous contribution he has made to Halma's success over the past decade. Geoff had the unenviable task of taking over from Halma's founder, David Barber, who had created a business with an impressive 30-year track record. Under Geoff's chairmanship, the Group has not only maintained that track record but, as a result of sustained focused investment, is now better placed to continue that success in the future. Thanks Geoff.

 

During the year, we welcomed Paul Walker to Halma's Board.  HITE 2013 provided a great chance for Paul to see the whole Group and start to appreciate some of the opportunities and challenges ahead. I look forward to working closely with Paul when he takes up the Chairman's role after this year's AGM.  Welcome, Paul.

 

Outlook

During the past year, we have continued to strengthen our business by further increasing investment in our drivers of organic growth - innovation, people development and international expansion. We have significantly improved the fundamental quality of our portfolio through six acquisitions and one disposal.

 

Order intake since the start of 2013 has been consistent with our expectations of sustaining year-on-year organic growth and high returns. We remain confident that Halma will make further progress in the year ahead.

 

Andrew Williams, Chief Executive

See Financial Highlights.
See Note 2 to the Preliminary Statement.

 

 

 

 

Financial Review

 

Halma's financial model sustaining success

Once again Halma delivered record results, achieving growth coupled with high returns. Strong cash generation funded the continuation of our long-term record of dividend increases. International expansion continues to be a key part of our story as does M&A, with considerable success in the year in making six acquisitions and one disposal. Our financial position remains strong.

 

Record revenue and profit

Revenue increased by 6.8% to £619.2m (2012: £579.9m), up £39.3m. Of this increase, acquisitions in 2012/13 and the prior year, net of disposals, contributed £26.5m so organic revenue was up 2.2%. There was a small adverse impact from currency translation and consequently organic revenue growth at constant currency was 2.9%.

 

Revenue and profit growth




Percentage change




2013
£m



2012
£m



Increase
£m




Total



Organic
growth*

Organic
growth* at
constant
currency

Revenue

619.2

579.9

39.3

6.8%

2.2%

2.9%

Adjusted1 profit

130.7

120.5

10.2

8.5%

4.1%

5.3%








* Organic growth2 is calculated excluding the results of acquisitions and disposals.

 

This is the tenth consecutive year of record results with adjusted1 profit before taxation growing by 8.5% to £130.7m (2012: £120.5m). Organic profit growth was 4.1% and adjusting for adverse currency translation impacts, organic profit growth at constant currency was 5.3%.

 

Statutory profit before taxation grew by 9.2% to £122.3m. Statutory profit is after charging the amortisation of acquired intangible assets of £14.2m (2012: £10.4m), acquisition transaction costs and movements on acquisition contingent consideration including related foreign exchange movements of £2.3m (2012: £1.6m) and after crediting the profit on disposal of Tritech of £8.1m.

 

Revenue growth was 7% in the second half of the year following a 6% increase in the first half. Adjusted1 profit grew by 11% in the second half, following a 6% increase in the first half, so the first half/second half split of profit was 47%/53%, with the revenue split at 48%/52%. This is consistent with previous years, with higher revenue and profitability in the second half of the year.

 

Sector reporting changes

As announced on 14 February 2013 we are reporting Group performance under four market based sectors. This evolution in our reporting follows significant growth in the former Health & Analysis sector. Comparative figures have been restated (see Note 2 to the Preliminary Statement).

 

We saw the highest growth this year in the Medical sector. There was a small decline in the Environmental & Analysis sector where we anticipate reorganisation costs of approximately £1m in the first half of 2013/14 to underpin improved future performance. In 2012/13 costs of £0.8m were charged in the Group Income Statement, mainly in the first half of the year, in relation to the successful reorganisation of certain Infrastructure Safety businesses.

 

Central administration costs increased in the year predominantly to finance continued global expansion and people development activity including our new Halma Graduate Development Programme.

 






2013


2012



 


£m

% of
 total



£m

% of
 total

Change
£m
 

% 
growth
 

United States of America

195.0

31%


162.0

28%

33.0 

20% 

151.6

25%


154.4

27%

(2.8)

(2%)

115.6

19%


125.6

21%

(10.0)

(8%)

100.5

16%


87.3

15%

13.2 

15% 

Other countries

56.5

9%


50.6

9%

5.9 

12% 


619.2

100%


579.9

100%

39.3 

7% 

 

Strong growth in USA and Asia Pacific

The geographic revenue growth pattern was very consistent between the first and second half. The USA continues to be our largest sales destination growing by 20% this year and accounting for 31% (2012: 28%) of Group revenue. Acquisitions boosted the US growth and there was 4% organic growth at constant currency. Mainland Europe revenue was only 2% below the prior year despite the tough economic environment, with the Medical sector achieving more than 20% growth there. UK revenue declined by 8%, although excluding the impact of disposals in the current and prior year the revenue decline was only 3%. Asia Pacific grew strongly at 15% with all four sectors growing in this region. China revenue was up 25% and is now almost 6% of Group revenue.

 

We are targeting to have 30% of Group revenue coming from outside the UK/Mainland Europe/USA by 2015 and this percentage increased from 23.8% last year to 25.4% this year. This shows good progress and compares with a figure of 19% five years ago. Half of our revenue growth this year came from outside the UK/Mainland Europe/USA.

 

Increased Return on Sales

Group Return on Sales has been above 16% for the last 28 consecutive years. Our current target is to operate in the 18% to 22% range. We believe that a consistently high Return on Sales is a key indicator of the value our customers place on our products and of good cost management. In 2012/13 Return on Sales increased once again to 21.1% (2012: 20.8%) due to M&A activity and the mix of strong business performances. In the second half of the year Return on Sales was 21.8%.

 

A high Gross Margin (revenue less direct material and direct labour costs) remains a stable element of our profitability and this year increased to 64.0% (2012: 63.5%), a good achievement against the background of cost and price pressures, reflecting the value of our increasing investment in customer-led innovation.

 

Currency rates





Weighted average rates used in
Income Statement


Year end exchange rates used 
to translate Balance Sheet 


2013

2012


2013 

2012 

US Dollar

1.58

1.60


1.52 

1.60 

Euro

1.23

1.16


1.19 

1.20 

 

Currency impacts

Halma reports its results in Sterling. The most important other trading currencies are the US Dollar, Euro, and to a lesser extent the Swiss Franc. Approximately 40% of Group revenue is denominated in US Dollars and 14% in Euros.

 

The Group has both translational and transactional currency exposure. Translational exposures arise on the consolidation of overseas company results into Sterling. Transactional exposures arise where the currency of sale or purchase transactions differs from the functional currency in which each company prepares its local accounts.

 

We take a neutral view of the future movements of currencies. After matching currency of revenue with currency costs wherever practical, forward exchange contracts are used to hedge a proportion (up to 75%) of the remaining forecast net transaction flows where there is a reasonable certainty of an exposure. We hedge up to 12 months and in certain specific circumstances 24 months, forward. At 30 March 2013 over 50% of our next 12 months currency trading transactions were hedged. There is a good degree of natural hedging within the Group in US Dollars but we typically buy fewer products in Euros than we sell and so have a net exposure of approximately €30m at any time.

 

There was a small negative net currency translational impact on the 2012/13 results. Relative to Sterling the US Dollar strengthened by 1% and the Euro weakened by 6% on average in the year and the net currency translation impact was 0.7% adverse on revenue and 1.2% adverse on profit.

 

Based on the current mix of currency denominated revenue and profit, a 1% movement in the US Dollar relative to Sterling changes revenue by £2.4m and profit by £0.5m. Similarly, a 1% movement in the Euro changes revenue by £0.9m and profit by £0.2m.

 

Increased finance cost

Net financing cost in the Income Statement increased to £3.8m (2012: £1.4m). Net bank interest and funding costs increased due to higher average levels of debt and slightly higher average interest rates (see table 'Average debt and interest rates' below) as well as the higher costs of funding our increased bank facility from October 2011.

 

The net pension financing charge is also part of our financing cost and this year it increased from £0.2m to £0.5m. This charge is dependent on the level of pension scheme liabilities and assets at the start of the year as well as the discount rate/rates of return applied to them. In 2012/13 the cost of higher liabilities exceeded the return on increased assets. In 2013/14 the pension accounting rules under IAS19 (Employee benefits) will change and this change will affect the Group Income Statement. The principal change relates to the requirement to use the schemes' discount rate to calculate the return on assets rather than using a rate of return appropriate to the various asset classes. At current discount rates, the change is expected to reduce the adjusted profit by approximately £2m for 2013/14 onwards. Comparative figures will be similarly restated, so overall Group reported growth rates will be largely unaffected.

 

Higher Group tax rate

The Group has its main operating subsidiaries in 14 countries so the Group's effective tax rate is a blend of these different national rates applied to locally generated profits. Our approach to taxation is to manage the tax burden in a responsible manner, keeping good relationships with tax authorities based on legal compliance, transparency and cooperation. Intercompany trading is set on a commercial arm's length basis.

 

The effective tax rate on adjusted1 profit increased to 24.2% (2012: 23.5%). Approximately one-third of Group profit is generated and taxed in the UK and the UK Corporation Tax rate fell from 26% to 24% this year, with it forecast to fall to 20% in 2016. Offsetting this was the tax on increased profits generated in higher tax rate jurisdictions, in particular the USA.

 

We anticipate that the effective tax rate in 2013/14 will be similar to that in 2012/13.

 

Increasing earnings per share and dividends

We have consistently delivered value to shareholders through growth in earnings per share and dividend increases. Adjusted2 earnings per share increased by 7.2% to 26.22p below the rate of increase in adjusted2 profit due to the higher effective tax rate compared with the prior year. Statutory earnings per share increased by 9.6% with the higher acquisition related expense being more than offset by the £8.1m profit on disposal of Tritech.

 

An increase in the final dividend of 7.1% to 6.37p per share (2012: 5.95p) is recommended which, together with the 7.1% increase in the interim dividend, gives a total dividend of 10.43p per share (2012: 9.74p). Halma has a long record of growing its dividend, and with this latest rise, will have increased the dividend by 5% or more for every one of the last 34 years, paying out £300m to shareholders in the last decade. The final dividend for 2012/13 is subject to approval by shareholders at the AGM on 25 July 2013 and will be paid on 21 August 2013 to shareholders on the register at 19 July 2013.

 

We have maintained a progressive dividend policy that balances dividend increases with organic growth rates achieved, taking into account current and potential acquisition spend and the maintenance of moderate debt levels. Dividend cover (the ratio of adjusted profit after tax to dividends paid and proposed) remains the same as 2012 at 2.5 times. Our policy is to maintain dividend cover, based on adjusted profit, above two times and we will continue to monitor dividend payout each year as dividend cover rises.

 

Good cash generation

Strong cash generation is critical to the long-term health of the Group. Our cash performance in 2012/13 was good. Adjusted operating cash flow was £113.7m (2012: £105.4m) and represents 84% (2012: 86%) of adjusted operating profit. This new cash conversion KPI is in keeping with best practice amongst our peers and this year's result is in line with our newly revised KPI target of 85% cash conversion.

 


Operating cash flow summary

2013 
£m
 

2012 
£m
 

Operating profit

118.4 

109.9 

Net acquisition costs and contingent consideration
fair value adjustments


2.2
 


1.7 

Amortisation of acquisition-related acquired intangibles

14.2 

10.4 

Adjusted operating profit

134.8 

122.0 

Depreciation and other amortisation

17.7 

17.3 

Working capital movements

(10.9)

(7.6)

Capital expenditure net of disposal proceeds

(14.6)

(15.3)

Additional payments to pension schemes

(8.3)

(6.4)

Other adjustments

(5.0)

(4.6)

Adjusted operating cash flow

113.7 

105.4 

Cash conversion %

84% 

86% 

 

 

Non-operating cash flow and reconciliation to net debt

2013 
£m
 

2012 
£m
 

Adjusted operating cash flow

113.7 

105.4 

Tax paid

(25.5)

(27.8)

Acquisition of businesses and shares of associates including cash/debt acquired

(153.7)

(19.8)

Net finance costs and arrangement fees

(2.3)

(3.2)

Dividends paid

(37.8)

(35.2)

Issue of shares/treasury shares purchased

(5.1)

(3.5)

Disposal of businesses

19.6 

3.6 

Effects of foreign exchange

(0.5)

(1.1)

Movement in net debt

(91.6)

18.4 




Opening net debt

(18.7)

(37.1)




Closing net debt

(110.3)

(18.7)

 

 


Net debt to EBITDA

2013 
£m
 

2012 
£m
 

Operating profit

118.4 

109.9 

Depreciation and amortisation

31.9 

27.7 

EBITDA

150.3 

137.6 




Net debt to EBITDA %

73% 

14% 

 

A summary of the year's cash flow is shown in the table above. Working capital movements, comprising changes in inventory, debtors and creditors, totalled £10.9m (2012: £7.6m). Working capital management is the responsibility of each individual subsidiary board and therefore receives close attention. This year's increase in debtors reflects the growth in our business and receives continued focus to ensure cash generation remains strong.

 

Expenditure on property, plant and computer software this year was £15.5m (2012: £16.5m) slightly below the prior year when there were some larger capital investment projects. This year's spend represents 110% of depreciation, falling within the 100% to 125% range we expect.

 

Taxation paid was £25.5m (2012: £27.8m) a little below the relatively high prior year figure with a lower UK Corporation Tax rate and higher pension contributions contributing to the change.

 

Strong financial position

Halma is highly cash generative and has substantial bank facilities. We have access to competitively priced finance at short notice and spread our risks to provide good liquidity for the Group. Group treasury policy is conservative and no speculative transactions are allowed.

 

In October 2011 we refinanced our revolving credit facility. We have in place a £260m facility for five years to 2016 with five international banks. The Group continues to operate well within its banking covenants. We use debt to accelerate the Group's development and review our funding needs regularly to ensure we have ample headroom.

 

At the year end net debt was £110.3m (2012: £18.7m), a combination of £160.0m of debt and £49.7m of cash held around the world to finance local operations. The increased net debt is a result of our success in securing high quality acquisitions during the year offset by good cash generation and disposal proceeds. The ratio of net debt to EBITDA was 0.73 times (2012: 0.14 times), well below the level of 1.25 times within which we feel comfortable operating. Net debt represents 5.6% (2012: 1.3%) of the Group's year-end market capitalisation.

 

Average debt and interest rates

2013 

2012 

Average gross debt (£m)

133.7 

88.4 

Weighted average interest rates on gross debt

1.34% 

1.16% 

Average cash balances (£m)

45.2 

37.3 

Weighted average interest rate on cash

0.43% 

0.57% 

Average net debt (£m)

88.5 

51.1 

Weighted average interest rate on net debt

1.80% 

1.59% 

 

Record acquisition spend

Acquisitions and disposals are an important part of our growth model. We buy already successful businesses in, or adjacent to, niches in our chosen areas of operation.

 

During the year we spent £137m on six acquisitions (excluding net cash/(debt) acquired of £5m) plus £16m in payment of contingent consideration on acquisitions made in previous years. A provision has been made for £23m of contingent consideration on current year acquisitions, being our best estimate of the amounts likely to be payable. Goodwill of £82m and intangible assets of £69m were recognised on the acquisitions made in the year and the weighted average acquisition multiple was 9.2x EBIT, based on the initial acquisition consideration.

 

In August 2012 we sold Tritech for £22m. A gain of £8.1m has been recognised in the Group Income Statement after accounting for the assets sold, including the associated goodwill. In April 2013 we made a further small acquisition for an initial consideration of £2.6m.

 

The businesses acquired in 2012/13 and in early 2013/14, together with the one disposal in 2012/13, are expected to add a net amount of £21.7m to revenue and £4.9m (after financing costs) to profit in 2013/14 based on their run rates at the time of acquisition/disposal.

 

Pension commitments

The Group primarily provides either defined benefit (DB) or defined contribution pension arrangements for its employees. The DB sections of the Group's pension plans were closed to new entrants in January 2003. There are now fewer than 400 employees retaining access to future accrual under the DB plans so our key focus is on mitigating the impact of the past service deficit.

 

On an IAS 19 basis the deficit on the DB plans at March 2013 was £47.2m (2012: £33.0m) before the related deferred tax asset. Plan assets increased to £176.3m (2012: £153.0m) with some further recovery in equity values and our additional cash contributions. In total, 57% of plan assets are invested in return-seeking assets; 35% in equities and 22% in diversified growth funds providing a higher expected level of return over the longer term. Plan liabilities increased to £223.5m (2012: £186.0m) mainly due to the reduction in the discount rate used to value these liabilities.

 

We continue to make extra contributions to the plans at a rate agreed with the trustees and expect this to be at the rate of £7m per year for the immediate future with the objective of eliminating the deficit over the next six years. We continue to develop and implement plans to reduce the risk in the future cost of our DB pension plans.

 

R&D investment

Expenditure on R&D increased to £31.1m (2012: £27.4m) an increase of 13% and representing 5.0% (2012: 4.7%) of revenue. All four sectors increased both the absolute spend and their percentage of revenue spent on R&D in the year. Environmental & Analysis has the highest spend per £ of revenue at 6.8%.

 

We are required under IFRS to capitalise certain development expenditure and amortise it over an appropriate period, for us three years. R&D by its nature carries risk and all R&D projects, particularly those requiring capitalisation, are subject to close scrutiny and a rigorous approval and review process. In 2012/13 we capitalised £5.4m (2012: £4.7m) and amortised £3.5m (2012: £3.7m). This results in an asset carried on the Consolidated Balance Sheet, after £0.4m of foreign exchange movements and disposals, of £12.0m (2012: £10.5m).

 

Managing risks and going concern considerations and the year ahead

The main risks facing the Group and how we address them are reviewed in the Principal Risks and Uncertainties section of this Preliminary Statement. The key operating risks are covered in the Chief Executive's Strategic Review and Sector Reviews.

 

A key risk mitigation is that we spread risk across the Group via well-resourced independent operating units. There are extensive and regular reviews of operations at local and Divisional levels. These reviews are supplemented by Internal Audit. As we expand our business internationally, we continue to focus on maintaining the quality of people and the controls operating across each country.

 

Our policies and processes to mitigate Bribery & Corruption together with our Code of Conduct have been rolled out across the Group including newly acquired businesses. This supports our long-standing ethical approach to business. In 2013/14 we will be supporting increased growth in subsidiary companies by further developing the strategic use of Information Technology having this year rolled out a centralised IT disaster recovery solution.

 

The Board considers all of the above factors in its review of 'Going Concern' as described in this Preliminary Statement and has been able to conclude its review satisfactorily.

 

Halma takes a disciplined approach to managing risk, to sustain high returns and deliver growth over the long term. In the year ahead we will continue to focus on strong cash generation to enable investment in existing and new businesses, finance dividends and deliver significant value to shareholders.

 

Kevin Thompson, Finance Director

1  In addition to those figures reported under IFRS Halma uses adjusted figures as key performance indicators. The Directors believe the adjusted figures give a more representative view of underlying performance. Adjusted profit figures exclude the amortisation of acquired intangible assets, acquisition and disposal costs, fair value adjustments on acquisition contingent consideration and profit on disposal of operations, all of which are included in statutory figures. More details are given in Note11.


2  See Financial Highlights.

 

 

 

 

Process Safety Sector Review

Products which protect assets and people at work

 

Specialised interlocks which safely control critical processes. Instruments which detect flammable and hazardous gases. Explosion protection devices.

 

Market trends

Rising expectations of workplace safety and increasingly stringent environmental and safety legislation continue to be strong demand drivers in both developed and developing Process Safety markets. We are also benefiting from improving enforcement of safety regulations. These positive market pressures ensure that our investment in quality, customer service, and enhanced-technology products maintains competitive advantage and underpins our significant growth in this sector.

 

Increased investment in new methods of oil and gas exploration has been a major boost to sales, particularly in hydraulic fracturing in shale oil and gas exploration, deep sea drilling, and LNG production and storage.

 

Geographic trends

Despite a challenging political and macro-economic environment, worldwide growth in demand for energy, food, chemicals and metals is set to continue. In particular, Asia Pacific and the Middle East are seeing increasing economic growth ahead of developed western economies. North American conditions continue to improve while Western Europe, due to recessionary pressures, is relatively flat.

 

Strategy

Our strategy focuses on driving organic growth through geographic diversification and investment in new product development to meet local market needs. Our companies in this sector now have 18 manufacturing sites across four continents. These are backed by 22 regional sales and service centres together with localised R&D to ensure that our products meet the diverse requirements of our customers.

 

We continue to develop strategic alliances between companies in this sector to optimise customer service. Internal collaboration delivers consistent product performance, service and applications advice worldwide. More partnerships with customers remain a key strategic goal.

 

Performance

Process Safety performed strongly with revenue up by 3% to £125.7m (2012: £122.2m) and profit1 increasing by 11% to £32.3m (2012: £29.2m). Excluding the contribution of Tritech, which was sold in August 2012, continuing operations revenue grew by 10% and profit by 16%. Organic revenue growth at constant currency was 10% with continued strong demand from energy and resources markets. Together with process industries these markets contribute around 60% of sector revenue and benefit from increasing Health and Safety regulation.

 

Return on Sales increased from 23.9% to 25.7% through a combination of strong revenue growth and gross margins supported by continuous improvement in new product innovation.

 

Organic revenue growth at constant currency for markets outside the UK, Mainland Europe and the USA was an impressive 29% resulting in these fast developing markets now representing 28% of the sector. Encouragingly, the performance in our traditional 'home' markets was robust with mid-single digit organic revenue growth in Mainland Europe and the USA and flat UK organic growth.

 

R&D investment rose to 4% of revenue. New products accounted for 34% of total sales reflecting an increased emphasis on new product development.

 

Outlook

Prospects for continued growth in the Process Safety sector are positive supported by forecasts of rising investment in oil, gas and energy markets. Food and pharmaceutical markets have regained resilience in the last year and planned safety legislation will continue to drive demand.

 

Automotive manufacturing has been flat or declining in the last two years but, based on industry sources, we anticipate increased investment, particularly in emerging markets.

 

We expect the strong growth trend in the Process Safety sector to continue, supported by rising R&D spend and expansion of regional operations.

 

We continue to search for Process Safety acquisition prospects, particularly in complementary markets to expand our product portfolio.

1 See Note 2 to the Preliminary Statement

 

 

 

 

Infrastructure Safety Sector Review

 

Products which detect hazards to protect assets and people in public spaces and commercial buildings

Fire and smoke detectors, security sensors and audible/visual warning devices. Sensors used on automatic doors and elevators in buildings and transportation.

 

Market trends

Increasing health and safety legislation is the main growth driver in our Infrastructure Safety sector. Fire regulations are being tightened up throughout Asia and in Europe new Construction Products Regulations (CPR) come into force in 2013.

 

The principal technology trend in fire detection is the packaging of multiple sensor technologies within a single detector to provide greater life safety protection and lower installation costs.

 

Fire detection system complexity is increasing and demand for voice alarms is growing faster than traditional audio-visual devices. Customers increasingly specify products with internationally recognised, rather than local, approvals.

 

In 2013 new European standards for visual alarm devices for fire systems will take effect. New harmonised European construction products regulations will also be implemented during 2013. We have developed new visual signalling products that meet the new regulations.

 

Competitive pressure is rising in our traditional pedestrian door markets; we continue to diversify into industrial and transportation automatic door control niches. New regulations are driving growth. In China, door sensor demand has stabilised, due to the construction slow down, but demand is strong in the Asia Pacific region.

 

New UK and European intruder detection system standards have created rising demand for our security sensors certified to meet the new regulations.

 

Geographic trends

In our largest regional sector, EMEA, we are seeing tough trading conditions continuing. Trading in Southern Europe has required enhanced credit risk control. Middle East demand remains strong but competitive pressure is increasing. Sales in China, SE Asia and Australia continued to grow. Opportunities exist across ASEAN countries which have a strong preference for 'branded systems' with UL or EN approvals, although there is also demand for lower cost products approved to less well-known standards.

 

In the USA the fast-growing 'home automation' market is providing opportunities. This market, which is the bundling of security, life safety, internet services, healthcare monitoring, energy management etc., is focused on existing homeowners and does not depend on 'new build' for growth.

 

Strategy

We are developing our presence in higher growth areas such as Russia and Eastern Europe, ASEAN nations and Brazil. We have also entered adjacent markets, such as life-safety carbon monoxide detectors and home automation. We are achieving cost savings in our Chinese plants which feed our European and American operations. In some undeveloped territories, we are forging new partnerships by offering IP-protected, UL-approved technology to enable fire market entry by building management and security companies.

 

Our door sensor business is focused on new product development for targeted industrial and transport niches to diversify our customer base and reduce dependence on the pedestrian doors sector. In keeping with other Halma sectors, R&D has also been decentralised from headquarters with increased spending on product development at our US and Chinese facilities. New sensors developed in China and in the USA will contribute significantly to sales revenues in the future.

 

Our technology strategy is to maintain competitive advantage in wireless security products designed for commercial environments. We are positioning our security business to offer more integrated building monitoring solutions via technology partnerships with other manufacturers, including those within Halma.

 

Performance

Infrastructure Safety delivered another solid year. Revenue increased 1% to £205.3m (2012: £204.3m) and profit1 grew by 7% to £41.8m (2012: £39.1m). Return on Sales improved from 19.1% to 20.3% with a significant factor being the improved profitability following the reorganisation of our companies selling elevator products. Organic revenue growth at constant currency was 1% which, following a flat first half, reflected a slight improvement during the second half. This resilience in demand comes from our focus on safety-critical product niches for regulated non-residential applications. Approximately two-thirds of sector revenue is installed in existing infrastructure rather than new construction.

 

New product introductions and increased investment in sales resources contributed to strong growth in the USA where organic revenue growth (constant currency) was 18%. Elsewhere we saw modest rates of growth in the UK and Asia Pacific while, unsurprisingly, almost every business in this sector experienced difficult conditions in Mainland Europe, resulting in organic revenue decline there of 8%.

 

Outlook

We anticipate continued Infrastructure Safety growth due to technology advances, regulatory pressure and new localised products. European demand for certified products will be a principal driver and we are well-placed to benefit from wider adoption of integrated building monitoring systems and intruder alarms based on wireless communication.

 

Growth in mature markets will be modest, while developing economies will grow strongly. Russia, Eastern Europe, Middle East, Latin America, ASEAN nations and China all offer good growth potential. In the USA and Western Europe legislation-driven adjacent markets offer good growth prospects.

 

1 See Note 2 to the Preliminary Statement

 

 

 

 

Medical Sector Review

Products used to improve personal and public health

Devices used to assess eye health, assist with eye surgery and primary care applications. Fluidic components such as pumps, probes, valves and connectors used by medical diagnostic OEMs.

 

Market trends

Medical market growth drivers are principally worldwide population ageing, increasing life expectancy, increasing access to healthcare in developing economies, new technologies and improved or new surgical or pharmaceutical therapies.

 

The proportion of people aged over 60 continues to rise and drives demand for healthcare both in developed and developing geographies. Population ageing is a key driver for our ophthalmology and hypertension management businesses since these health issues are age-related.

 

A key medical niche, the ophthalmic diagnostic equipment market, will grow at 2.5% from 2009 to 2016 as new technologies, population ageing and rising healthcare expectations and affordability in developing economies continue to underpin demand.

 

The global market for cataract surgery devices is forecast to grow at a compound annual growth rate of 3% between 2010 and 2017. Growth drivers include rising demand for surgery due to population ageing and technological advances such as micro-incision eye surgery.

 

Regulatory compliance and medical product approvals, particularly in China and Brazil, continue to get tougher and more costly. This delays returns from new products, increases development costs and puts pressures on margins. On the plus side, rigorous regulatory regimes create higher barriers to entry for new competitors.

 

The in-vitro medical diagnostic market, our largest fluidic components niche, is largely concentrated in the US. In recent years uncertainty over healthcare reforms has dampened demand. The USA healthcare market has returned to growth with rising sales for existing platforms and higher activity in customers' new product development pipelines. Growth in Asia is expected to outpace other geographies, with a forecast market growth rate to 2016 of 11.8% for the region, and 18.8% in China.

 

Geographical trends

The US Government is seeking healthcare budget cuts but the Patient Protection and Affordable Care Act (PPACA) will increase spending. In 2013 US health costs are projected to rise by 3.8%. The situation changes dramatically in 2014 when twenty-two million more Americans gain healthcare insurance and spending is predicted to rise by 7.4%. The PPACA also introduces a 2.3% Medical Device Tax on medical products.

 

Financial austerity in Europe continued to depress demand. Despite recessionary pressure, a return to growth is forecast in the medium term. Industry analysts predict average European medical device market growth of 1.6% per year between 2014 and 2018.

 

We continued to invest in sales resources and new medical distribution channels in Asia and South America. Brazil, with a population of over 190 million and a well-developed, expanding healthcare system, is the largest South American medical equipment market and forecast to grow by 12.6% CAGR between 2011 and 2015. Our São Paulo facility has now achieved ANVISA2 registration from the Brazilian government which lets us gain approvals for healthcare products in our own name.

 

Economic development across Asia is rapidly increasing access to healthcare. In China, where healthcare is a key social priority, medical spending is forecast to rise by almost three times between 2011 and 2020. Demographic drivers are producing a rapid increase in chronic conditions like diabetes and hypertension (high blood pressure) as populations age, people move to cities and lifestyles change. About 130 million Chinese between the ages of 35 and 74 suffer from hypertension. Increased awareness of this health issue, and programmes to combat it, will increase demand for hypertension diagnosis devices.

 

In China we established an R&D unit to drive localised product development. Our recently acquired US-headquartered blood pressure monitoring business adds an 80 person manufacturing and R&D centre in Shenzhen.

 

Strategy

Our Medical sector strategy is to increase organic growth through:

 

·     innovative new products

·     penetration of new geographical markets

·     expansion into adjacent market niches.

 

Acquisition of additional value-enhancing healthcare businesses will also add significant further growth. We aim to increase R&D investment, particularly in ophthalmology and hypertension management. Focusing on Asia and South America, market extension will be achieved through additional sales resources, sales intelligence sharing and cooperative marketing between Group companies, and new channel partnerships.

 

Our focus on relatively low-cost medical devices avoided the impact of government austerity budget cutbacks which mainly affected capital equipment.

 

Local manufacture in emerging markets, to better satisfy local customer needs and strengthen competitiveness by avoiding import tariffs, is a key strategic medical sector goal. From 2013, we plan to assemble health optics products in Brazil.

 

Our fluidic components businesses aim for increased customer diversification, focusing on laboratory and health-care markets. They now have joint product development teams and sell into the Chinese medical diagnostics sector jointly via a new Halma Fluid Technology business unit.

 

Performance

Medical had an outstanding year, increasing revenue by 36% to £136.1m (2012: £100.4m) and profit1 by 37% to £35.9m (2012: £26.3m). Return on Sales increased further from 26.2% to 26.4%. The underlying organic revenue growth (constant currency) was 12%. As expected, slowly improving demand for fluid control components from major medical OEM customers, steady growth in ophthalmology markets and our increased product innovation were the significant contributory factors to this excellent result.

 

Our strategic focus on small medical devices and components rather than high value capital equipment, enabled us to mitigate the negative impact from government austerity spending cuts in certain markets. The fundamental market drivers of an ageing population in the West and a growing and wealthier population in the East, give us continued confidence for the future.

 

Both the USA and Mainland Europe performed well with organic revenue growth (constant currency) of 12% and 17% respectively, whilst the UK saw organic revenue decline of 3%. Revenue from outside these three major territories increased organically by 12%, to now represent 25% of the sector. Our real exposure to these faster growing markets is greater, as a sizeable proportion of our revenue from the USA and Mainland Europe is to global OEMs who subsequently export their finished systems to other global regions.

 

Three new US-based businesses acquired in 2012 expanded our healthcare technology portfolio and extended our geographic reach. We added ultrasound technology to our ophthalmic diagnostic instrumentation, new hypertension management technology and new single-use surgical devices.

 

Outlook

Ageing populations in developed economies and rising populations with access to affordable healthcare in the developing world should create continued favourable conditions for growth. We anticipate consistently rising sales into the healthcare and medical diagnostics markets driven by enhanced distribution in export markets, new products and further acquisitions.

 

Growth in South East Asia should remain strong as governments continue to improve their healthcare systems. China will build thousands of new hospitals in the next few years. Investment in Chinese product registrations should deliver rising sales. Growth in Brazil should accelerate based on our new regulatory status.

 

1 See Note 2 to the Preliminary Statement

2 ANVISA - Brazilian National Health Surveillance Agency responsible for regulation of medical devices.

 

 

 

 

Environmental & Analysis Sector Review

Products and technologies for analysis in safety, life sciences and environmental markets

 

Market-leading opto-electronic technology and gas conditioning products. Products to monitor water networks; UV technology for disinfecting water; and water quality testing products.

 

Market trends

In the Environmental & Analysis sector our businesses serve a very diverse range of end-user markets. The underlying growth drivers are rising demand for basic resources such as energy and water, increasing environmental monitoring and regulation and demand for healthcare.

 

Water quality, water scarcity and the need to reduce water treatment energy costs are the key drivers behind increasingly strict regulation and growth in demand for our water analysis and water and wastewater treatment systems. These drivers are assuming ever greater importance due to population growth, urbanisation and climate change. The market for water disinfection systems is estimated to be growing annually by 10% to 12% and water monitoring demand is growing by 5% per year.

 

Independent product validations are becoming increasingly important in water treatment. We expect continued investment by industrial customers, driven by legislation, but difficult market conditions in the municipal segment. We anticipate significant sales growth in the marine Ballast Water Treatment (BWT) market. The BWT market is forecast to grow by over 50% a year between 2009 and 2020.

 

We anticipate continued steady growth from three core end-user markets: environmental monitoring, biotechnology and chemical analysis. Worldwide growth in these markets is driven by increasing environmental legislation and healthcare initiatives. Rising concern over food safety, adulteration and contamination is creating growing sales opportunities in both developed and developing economies.

 

The global environmental monitoring market is predicted to grow by 6.5% per year between 2011 and 2016. Strong annual growth of 6% is also forecast for the laboratory analytical market over the same period.

 

Concern over climate change is another driver of demand for our analytical instruments, water conservation and energy management technology. Throughout the world governments are continually introducing new legislation and initiatives designed to improve energy efficiency and reduce carbon dioxide output.

 

Geographic trends

With such diverse end-markets, the geographic trends are diverse too. However, we see opportunities for growth in all global regions although the ratio of growth in Asia, and China in particular, is expected to be higher.

 

For example, China now has over 30 laws and 1,000 separate regulations to prevent pollution and protect natural resources. China recently introduced stricter air pollution monitoring standards which should increase demand for our products that monitor sources of pollution and measure air quality.

 

Like many countries, China faces the challenge of rising water demand while available water resources are actually falling. The market for water treatment products in China is forecast to grow at 10% annually to 2015 with the industrial market offering the largest growth opportunities.

 

Strategy

We will maintain world leadership in systems which reduce loss of treated water in distribution networks via technological leadership. This will be supported by newly acquired 'machine-to-machine' communication technology which is in increasing demand for environmental data collection and is built into smart meters for remote data recording.

 

Our strategy for opto-electronic analytical products is to grow organic profit by extending our offering in the life sciences and environmental monitoring sectors. To reduce the cyclical impact of US federal spending programmes, we are repositioning these businesses to service a higher proportion of end users in non-government funded markets.

 

We work closely with both academic and commercial researchers to develop innovative new technologies and solutions. In China, for example, we are involved with 12 university science labs. This basic science strategy reveals new product niches and revenue streams when research is commercialised.

 

Performance

Environmental & Analysis had a relatively disappointing year as revenue declined by 1% to £152.4m (2012: £153.4m) and profit1 reduced by 4% to £30.4m (2012: £31.6m). Return on Sales was 19.9% (2012: 20.6%). Organic revenue at constant currency was down 6%. Reduced government research spending in the USA and lower investment by water utilities in the UK were the two major adverse market factors.

 

These market factors are clearly reflected in the regional trends with organic revenue (constant currency) declines of 14% in the UK and 10% in the USA. Organic revenue from Mainland Europe fell by 4%. Our companies continue to invest in growth in markets outside the UK, Mainland Europe and the USA with revenue from these developing markets being 27% of the total sector, contributing organic growth of 6%.

 

Outlook

Despite the challenges faced by Environmental & Analysis in the past year, we are confident that the management and organisational changes currently being made will improve performance in future.

 

These include simplifying global sales channels and manufacturing operations together with increasing senior management resources to focus on accelerating growth in Asia and from recent new technology innovation. It is expected that the total cost of this reorganisation will be around £1m in 2013/14. 

 

1 See Note 2 to the Preliminary Statement

 

 

 

 

Principal Risks and Uncertainties

 

Risk description

Potential impact

Mitigation

 

Operational Risk

Remoteness of operations and globalisation

A key operational risk emanates from remoteness of operations from Head Office and the increasing global spread of our businesses.

 

• Weakening of financial control and divergence from overall Group strategy in remote operations, leading to unexpected financial outcomes

• Failure to comply with local laws and regulations in unfamiliar territories, leading to legal or regulatory disputes

 

 

• Control is exercised locally in accordance with the Group's policy of autonomous management. We seek to employ local high quality experts.

• The Group's acquisition model ensures retention of management and staff in acquired businesses meaning that local expertise is maintained.

• Divisional Chief Executives (DCEs) ensure that overall Group strategy is fulfilled through on-going review of the businesses. The right balance between autonomy and adherence to the overall objectives of the Group is a key function of the DCEs and Divisional Finance Directors.

• Regular visits by senior management, finance staff and Internal Audit support local control.

Key KPIs:  International expansion; Values alignment; Development programmes

 

 

Operational Risk

Staff quality

The actions and quality of our employees affect the growth of, and level of innovation in, the business.

 

• Failure to retain key staff could lead to reduced innovation and progress in the business

• Unethical actions of staff could cause reputational damage to the Group

 

 

• Group Development Programmes enhance the skills of executives and middle managers needed in their current and future roles.

• Comprehensive recruitment and ongoing evaluation processes assist high quality hiring and development.

• The Group regularly surveys staff to assess the alignment of individuals with Group values.

Key KPIs:  Development programmes; R&D investment; Values alignment; Organic revenue growth

 

 

Operational Risk

Competition

The Group faces competition in the form of pricing, service, reliability and substitution.

 

• Loss of market share due to price pressure and changing markets

• Reduced financial performance arising from competitive threats

 

• By empowering and resourcing innovation in local operations to respond to changing market needs, the potential adverse impact of downward price pressure and competition can be mitigated and growth maintained.

• We recognise the competitive threat coming from emerging economies and by operating within these economies, typically using local staff, we are better placed to make fast progress ourselves.

• The Group operates in specialised global niche markets offering high barriers to entry.

Key KPIs:  R&D investment; Return on Sales; Organic revenue growth; Development programmes

 

 

Operational Risk

Pressure-point Exposures

including:

Large customer risk - individual operating companies are at some risk of over-reliance on larger customers

Key supplier risk - we rely on high quality service from our supply partners.

 

 

• Loss of market share and reduced financial performance due to loss or failure of a major customer

• Disruption of service to customers through supply chain interruption

 

• We do not place undue reliance on any one Group company nor does the Group rely heavily on one customer, supplier or transaction.

• We address customer concentration at Company level through active diversification of the customer base. No customer represents more than 2% of Group revenue.

• We aim to manage the risk of timing and quality of component supply by dual sourcing and through longstanding working relationships.

Key KPIs:  Organic revenue growth

 

Operational Risk

Research & Development

New products are critical to our organic growth and underpin our ability to earn high margins and high returns over the long term.

 

• Loss of market share resulting from product obsolescence and failure to innovate to meet customer needs

 

• By devolving control of product development into the autonomous operating businesses, we both spread risk and ensure that the people best placed to service the customer's needs are driving innovation.

• New product development 'best practice' is shared between Group companies and return on investment of past and future innovation projects is tracked monthly. This ensures that the collective experience and expertise of the Group can be utilised to maximum effect.

• Large R&D projects, especially those which are capitalised, require Head Office approval, ensuring that the Group's significant projects are aligned to overall strategy.

Key KPIs:  R&D investment; Development programmes

 

 

Operational Risk

Intangible resources

Protection of our intellectual property builds competitive advantage by strengthening barriers to entry. Our intangible resources include patents, product approvals, technological know-how, branding and our workforce.

 

 

• Loss of market share resulting from a failure to protect key intellectual property

 

• Workforce quality and retention is a central objective. This focus ensures that intangible resources stay and grow within the business.

• Operating businesses are actively encouraged to develop and protect know-how in local jurisdictions.

• Innovation is encouraged and fostered throughout the Group via the Halma Innovation Awards.

 

Key KPIs:  Organic revenue growth; R&D investment; Development programmes

 

Operational Risk

Information Technology/Business Interruption

Group and operational management depend on timely and reliable information from our software systems. We seek to ensure continuous availability, security and operation of those systems.

 

 

• Delay or impact on decision making through lack of availability of sound data

• Reduced service to customers due to poor information handling or interruption of business

 

 

• There is substantial redundancy and back up built into Groupwide systems and the spread of business offers good protection from individual events.

• We have a small central resource, Halma IT Services, to assist Group companies with strategic IT needs and to ensure adequate IT security policies are used across the Group.

• We carry out regular IT audits.

• We utilise external penetration testing and have completed the rollout of a centralised IT disaster recovery solution to supplement local processes. Business Continuity plans are well advanced in each business unit.

 

Strategic Risk

Acquisitions

The identification and purchase of businesses which meet our demanding financial and growth criteria is an important part of our strategy for developing the Group, as is ensuring the new businesses are rapidly integrated into the Group.

 

• Failure to deliver expected results resulting from poor acquisition selection

• Reduced financial performance arising from failure to integrate acquisitions into the Group

• Unforeseen liabilities arising from a failure to understand acquisition targets fully

 

 

• We acquire businesses whose technology and markets we know well. Divisional Chief Executives are responsible for finding and completing acquisitions in their business sectors subject to Board approval supported by central resources to search for opportunities. We employ detailed post-acquisition integration plans.

• Thorough due diligence is performed by a combination of in-house and external experts to ensure that a comprehensive appraisal of the financial position of every target is obtained.

• Incentives are aligned to encourage acquisitions which are value-enhancing from day one.

Key KPIs:  Acquisition spend; ROTIC

 

Legal Risk

Laws and regulations

Group operations are subject to wide-ranging laws and regulations including business conduct, employment, environmental and health and safety legislation. There is also exposure to product litigation and contractual risk.

The laws and regulations we are exposed to as our businesses expand around the world increase each year.

 

• Reputational damage leading to customer loss and brand damage

• Diversion of management resources creating opportunity costs

• Penalties arising from breach of laws and regulations

 

• The Group's emphasis on excellent financial control, high ethical standards, the deployment of high quality management resource and the strong focus on quality control over products and processes in each operating business help to protect us from product failure, litigation and contractual issues.

• Each operating company has a health and safety manager responsible for compliance and our performance in this area is good. Updated Health and Safety policies and guidance were issued recently, with enhanced monthly reporting. Our well established policies on bribery and corruption have been maintained during the year to ensure continued compliance with best practice internally, via the Group Code of Conduct and externally, via appropriate clauses included in third party agreements.

• We carry comprehensive insurance against all standard categories of insurable risk. Contract review and approval processes mitigate exposure to contractual liability.

Key KPIs:  Values alignment

 

 

Financial Risk

Cash

A key risk is that the Group may run out of cash or not have access to adequate cash. In addition, cash deposits need to be held in a secure form and location.

 

• Constraints on, or inability to, trade

• Inability to deliver on growth strategies

• Permanent loss of shareholder funds

 

 

• The strong cash flow generated by the Group provides financial flexibility.

• Cash needs are monitored regularly. In addition to short-term overdraft facilities the Group renewed and increased to £260m its five-year revolving credit facility during the prior year providing security of funding and sufficient headroom for its needs. Debt levels increased this year but the Group has adequate funding available to it.

• Cash deposits are monitored centrally and spread amongst a number of high credit rated banks. Subsidiaries report their cash status to Head Office every week.

Key KPIs:  Cash generation

 

 

Financial Risk

Treasury Risks

Foreign currency risk is the most significant treasury related risk for the Group. In times of increased volatility this can have a significant impact on performance. The Group is exposed to a lesser extent to other treasury risks such as interest rate risk and liquidity risk.

 

• Reduced or volatile financial performance arising from translation of profit from overseas operations or poorly managed foreign exchange exposures

• Deviation from core strategy through the use of speculative or overly complex financial instruments

• Financial penalties and reputational damage arising from breach of banking covenants

 

 

• The risk has increased because more of the Group's profits are derived from non-Sterling currencies. Currency profits are not hedged. Currency hedging must fit with the commercial needs of the business and we have in place a hedging strategy to manage Group exposures. This requires the hedging of a substantial proportion of expected future transactions up to 12 months (and in exceptional cases 24 months) ahead. Longer term currency trends can only be covered through a wide geographic spread of operations.

• The Group does not use overly complex derivative financial instruments and no speculative treasury transactions are undertaken.

• We closely monitor performance against the financial covenants on our revolving credit facility and are operating well within these covenants.

 

Financial Risk

Pension Deficit

Monitoring the funding needs of the Group's pension plans is essential to meeting our pension obligations effectively. Our UK defined benefit pension plans are closed to new members.

 

 

• Excessive consumption of cash, limiting investment

• Unexpected variability in company results

 

• There is regular dialogue with pension fund trustees and pension strategy is a regular Halma Board agenda item. The Group's strong cash flows and access to adequate borrowing facilities mean that the pensions risk can be adequately managed.

• The Group has maintained additional pension contributions with the overall objective of paying off the deficit in line with the Actuary's recommendations. We monitor and consider alternative means of reducing our pension risk in light of the best long-term interest of shareholders.

 

Economic Risk

Economic Conditions

In times of uncertain economic conditions businesses face additional or elevated levels of risk. These include market and customer risk, customer default, fraud, supply chain risk and liquidity risk. Uncertainty in the Eurozone in particular adds to current uncertainty.

 

• Reduced financial performance

• Loss of market share

• Unforeseen liabilities

• Disruption of service to customers

 

 

• Risks are primarily managed at the operating company level where local knowledge is situated. The financial strength and availability of pooled finance within the Group mitigates local risks faced by operating companies as does the robust credit management processes in place across the Group.

• The Halma Executive Board identifies any wider trends which require action. Other than potential exposure to the current macro-economic uncertainty in the Eurozone, none have been noted.

• The Group's diversity limits its exposure to economic risk arising in any one territory. Group sales to Mainland Europe represent 25% of overall sales and sales to southern Eurozone economies and Ireland represent fewer than 5% of total Group sales. The Group does not have significant operations, cash deposits or sources of funding in these areas.

Key KPIs:  International expansion; Cash generation; Development programmes

 

 

 

 

 

Going Concern Statement

The Group's business activities, together with the main trends and factors likely to affect its future development, performance and position, and the financial position of the Group, its cash flows, liquidity position and borrowing facilities, are set out herein.

 

The Group has considerable financial resources (including a £260m five-year revolving credit facility, of which £105m was undrawn at 30 March 2013) together with contracts with a diverse range of customers and suppliers across different geographic areas and industries. No one customer accounts for more than 2% of Group turnover. The Directors have considered the Group's potential exposure to the Eurozone crisis and have concluded that this is minimal due to the fact that less than 5% of sales arise in areas experiencing macro-economic uncertainty and the Group does not maintain significant banking or other business relationships in these areas. As a consequence, the Directors believe that the Group is well placed to manage its business risks successfully.

 

After conducting a formal review of the Group's financial resources, the Directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Annual Report and Accounts.

 

 

 

 

Responsibility Statement of the Directors
on the Annual Report and Accounts

 

The responsibility statement below has been prepared in connection with the Company's full Annual Report and Accounts for the 52 weeks to 30 March 2013. Certain parts thereof are not included within this Preliminary Statement.

 

We confirm that to the best of our knowledge:

 

1.

the financial statements, prepared in accordance with the relevant financial reporting framework, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and

 

2.

the management report, which is incorporated into the Directors' Report, includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.

 

This responsibility statement was approved by the Board of Directors on 13 June 2013 and is signed on its behalf by:

 

 

A J Williams

Chief Executive

K J Thompson

Finance Director

 

 

 

 

Preliminary Statement for the 52 weeks to 30 March 2013

 

Consolidated Income Statement

 


52 weeks to 30 March 2013 

 


Notes

Before 

Adjustments*

£000 

Adjustments*

 (note 2)

£000 

Total 

£000 

Before 

Adjustments*

£000 

Adjustments*

(note 2)

£000 

Total 

£000 

Continuing operations








Revenue

2

619,210 

619,210 

579,883 

579,883 

Operating profit


134,844 

(16,477)

118,367 

121,944 

(12,034)

109,910 

Share of results of associates


(352)

(352)

(37)

(37)

Profit on disposal of continuing operations


8,070 

8,070 

3,543 

3,543 

Finance income

3

8,964 

8,964 

10,070 

10,070 

Finance expense

4

(12,795)

(12,795)

(11,512)

(11,512)

Profit before taxation


130,661 

(8,407)

122,254 

120,465 

(8,491)

111,974 

Taxation

5

(31,670)

4,632 

(27,038)

(28,256)

2,996 

(25,260)

Profit for the year attributable to equity shareholders

2

98,991 

(3,775)

95,216 

92,209 

(5,495)

86,714 


Earnings per share

6







From continuing operations








Basic


26.22p 


25.22p 

24.46p 


23.01p 

Diluted




25.19p 



22.97p 

 

Dividends in respect of the year

7







Paid and proposed (£000)




39,409 



36,723 

Paid and proposed per share




10.43p 



9.74p 

 

*  Adjustments include the amortisation of acquired intangible assets; acquisition transaction costs; movement on contingent consideration; profit on disposal of continuing operations; and the associated taxation thereon.

 

 

 

 

Consolidated Statement of

Comprehensive Income and Expenditure



52 weeks to 

30 March 
 2013
 

 £000 

52 weeks to 

31 March 

2012 

 £000 

Profit for the year


95,216 

86,714 





Exchange differences on translation of foreign operations and net investment hedge


16,534 

(5,707)

Actuarial losses on defined benefit pension plans


(21,970)

(3,024)

Effective portion of changes in fair value of cash flow hedges


(504)

545 

Tax relating to components of other comprehensive income


4,930 

(11)

Other comprehensive expense for the year


(1,010)

(8,197)





Total comprehensive income for the year attributable to equity shareholders


94,206 

78,517 

 

The exchange differences of £16,534,000 (2012: (£5,707,000)) comprise gains of £113,000 (2012: losses of £776,000) which relate to net investment hedges as set out in the Annual Report and Accounts 2013.

 

 

 

 

Consolidated Balance Sheet



30 March

2013

£000

31 March

2012

£000

Non-current assets




Goodwill


351,785

267,471

Other intangible assets


134,457

74,483

Property, plant and equipment


76,725

72,118

Interests in associates


4,792

1,968

Deferred tax asset


28,749

11,039



596,508

427,079

Current assets




Inventories


69,713

57,368

Trade and other receivables


133,605

114,674

Tax receivable


69

288

Cash and cash equivalents


49,723

45,305

Derivative financial instruments


256

469



253,366

218,104

Total assets


849,874

645,183

Current liabilities




Trade and other payables


100,929

93,499

Borrowings


5,147

-

Provisions


2,420

2,618

Tax liabilities


11,331

11,870

Derivative financial instruments


796

126



120,623

108,113

Net current assets


132,743

109,991

Non-current liabilities




Borrowings


154,866

64,014

Retirement benefit obligations


47,172

32,997

Trade and other payables


22,649

13,388

Provisions


2,100

2,301

Deferred tax liabilities


49,197

26,258



275,984

138,958

Total liabilities


396,607

247,071

Net assets


453,267

398,112

Equity




Share capital


37,888

37,856

Share premium account


22,598

22,177

Treasury shares


(4,534)

(4,569)

Capital redemption reserve


185

185

Hedging and translation reserve


45,372

29,212

Other reserves


(1,484)

1,346

Retained earnings


353,242

311,905

Shareholders' funds


453,267

398,112

 

 

 

 

Consolidated Statement of Changes in Equity


Share
capital

£000

Share premium account

£000

Treasury shares

£000

Capital redemption reserve

£000

Hedging and translation reserve

£000

Other
reserves

£000

Retained earnings

£000

Total

£000

At 31 March 2012

37,856

22,177

(4,569)

185

29,212

1,346

311,905

398,112

Profit for the year

-

-

-

-

-

-

95,216

95,216

Other comprehensive income and expense:









Exchange differences on translation of foreign operations

-

-

-

-

16,534

-

-

16,534

Actuarial losses on defined benefit pension plans

-

-

-

-

-

-

(21,970)

(21,970)

Effective portion of changes in fair value of cash flow hedges

-

-

-

-

(504)

-

-

(504)

Tax relating to components of other comprehensive income

-

-

-

-

130

-

4,800

4,930

Total other comprehensive income
and expense

-

-

-

-

16,160

-

(17,170)

(1,010)

Share options exercised

32

421

-

-

-

-

-

453

Dividends paid

-

-

-

-

-

-

(37,765)

(37,765)

Share-based payments

-

-

-

-

-

(2,835)

-

(2,835)

Deferred tax on share-based payment transactions

-

-

-

-

-

5

-

5

Excess tax deductions related to share-based payments on exercised options

-

-

-

-

-

-

1,056

1,056

Net movement in treasury shares

-

-

35

-

-

-

-

35

At 30 March 2013

37,888

22,598

(4,534)

185

45,372

(1,484)

353,242

453,267

At 2 April 2011

37,824

21,744

(5,016)

185

34,511

3,634

262,503

355,385

Profit for the year

-

-

-

-

-

-

86,714

86,714

Other comprehensive income and expense:









Exchange differences on translation of foreign operations

-

-

-

-

(5,707)

-

-

(5,707)

Actuarial losses on defined benefit pension plans

-

-

-

-

-

-

(3,024)

(3,024)

Effective portion of changes in fair value of cash flow hedges

-

-

-

-

545

-

-

545

Tax relating to components of other comprehensive income

-

-

-

-

(137)

-

126

(11)

Total other comprehensive income
and expense

-

-

-

-

(5,299)

-

(2,898)

(8,197)

Share options exercised

32

433

-

-

-

-

-

465

Dividends paid

-

-

-

-

-

-

(35,232)

(35,232)

Share-based payments

-

-

-

-

-

(2,082)

-

(2,082)

Deferred tax on share-based payment transactions

-

-

-

-

-

(206)

-

(206)

Excess tax deductions related to share-based payments on exercised options

-

-

-

-

-

-

818

818

Net movement in treasury shares

-

-

447

-

-

-

-

447

At 31 March 2012

37,856

22,177

(4,569)

185

29,212

1,346

311,905

398,112


Treasury shares are ordinary shares in Halma plc purchased by the Company and held to fulfil the Company's obligations under the performance share plan. At 30 March 2013 the number of treasury shares held was 1,143,209 (2012: 1,404,269) and their market value was £5,921,823 (2012: £5,344,648). The net movement of treasury shares of £35,000 (2012: £447,000) comprises the purchase of treasury shares of £5,525,000 (2012: £3,985,000) offset by the transfer to Other reserves of £5,560,000 (2012:
 £4,432,000).

 

The Hedging and translation reserve is used to record differences arising from the retranslation of the financial statements of foreign operations and the portion of the cumulative net change in the fair value of cash flow hedging instruments that are deemed to be an effective hedge. Other than a net charge of £247,000 (2012: income of £127,000), all amounts at year end relate to translation movements.

 

The Capital redemption reserve was created on repurchase and cancellation of the Company's own shares. The Other reserves represent the provision for the value of the equity-settled share option plans and performance share plan.

 

 

 

 

Consolidated Cash Flow Statement


Notes

52 weeks to

30 March 2013

 £000

52 weeks to

31 March

2012

 £000

Net cash inflow from operating activities

10

108,244

97,687





Cash flows from investing activities




Purchase of property, plant and equipment


(14,472)

(15,196)

Purchase of computer software


(1,044)

(1,293)

Purchase of other intangibles


(9)

(46)

Proceeds from sale of property, plant and equipment


917

1,244

Development costs capitalised


(5,443)

(4,718)

Interest received


195

212

Acquisition of businesses, net of cash acquired

8

(145,641)

(18,667)

Acquisition of investments in associates


(3,187)

-

Disposal of business, net of cash disposed

9

19,608

3,554

Net cash used in investing activities


(149,076)

(34,910)





Financing activities




Dividends paid


(37,765)

(35,232)

Proceeds from issue of share capital


453

465

Purchase of treasury shares


(5,525)

(3,985)

Interest paid


(2,502)

(1,490)

Loan arrangement fee


- 

(1,903)

Proceeds from borrowings

10

92,298 

76,456

Repayment of borrowings

10

(2,942)

(94,050)

Net cash from/(used in) financing activities


44,017

(59,739)





Increase in cash and cash equivalents

10

3,185

3,038

Cash and cash equivalents brought forward


45,305

42,610

Exchange adjustments


1,233

(343)

Cash and cash equivalents carried forward


49,723

45,305

 


2013

£000

2012

£000

Reconciliation of net cash flow to movement in net debt



Increase in cash and cash equivalents

3,185

3,038

Cash (inflow)/outflow from (drawdowns)/ repayment of borrowings

(89,356)

17,594

Net debt acquired

(2,406)

(1,144)

Loan notes issued*

(2,515)

-

Exchange adjustments

(489)

(1,119)


(91,581)

18,369

Net debt brought forward

(18,709)

(37,078)

Net debt carried forward

(110,290)

(18,709)

 

* The loan notes were issued on 6 June 2012 and were convertible at par into cash at any time between six and twelve months from date of issue. The loan notes were redeemed on 31 May 2013.

 

 

 

 

Notes to the Preliminary Statement

 

 

1  Basis of preparation

General Information

 

The Preliminary Statement is based on the Company's financial statements which are prepared in accordance with International Financial Reporting Standards (IFRS) adopted for use in the European Union (EU) and therefore comply with Article 4 of the EU IAS legislation and with those parts of the Companies Act 2006 that are applicable to companies reporting under IFRS.


There have been no significant changes in accounting policies from those set out in Halma plc's Annual Report and Accounts 2012. The accounting policies have been applied consistently throughout the years ended 31 March 2012 and 30 March 2013.

 

IAS 19 (as revised in June 2011) 'Employee Benefits' will be adopted by the Group for the financial year commencing 31 March 2013. The interest cost and expected return on defined-benefit pension scheme assets used in the previous version of IAS 19 are replaced with a 'net interest' amount, which is calculated by applying a discount rate to the net defined benefit liability or asset.

 

If IAS 19 (revised) had been applied to these financial statements, the profit for the year would have been approximately £2 million lower. Its adoption for the year to 29 March 2014 is expected to reduce the profit similarly by approximately £2 million. To aid comparison, in the 29 March 2014 Financial Statements, the 30 March 2013 comparatives will be restated as if IAS 19 (revised) had applied.

 

The financial information set out in this Preliminary Statement does not constitute the Group's statutory accounts for the years ended 30 March 2013 and 31 March 2012 but is derived from those accounts. Statutory accounts for 2012 have been delivered to the Registrar of Companies and those for 2013 will be delivered following the Company's Annual General Meeting. The auditors' reports on the 2012 and the 2013 accounts were unqualified, did not draw attention to any matters by way of emphasis without qualifying their report and did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

 

This Preliminary Statement was approved by the Board of Directors on 13 June 2013.

 

 

 

2  Segmental analysis

 

Sector analysis

 

The Group has four main reportable segments (Process Safety, Infrastructure Safety, Medical and Environmental & Analysis), which are defined by markets rather than product type. Each segment includes businesses with similar operating and marketing characteristics. These segments are consistent with the internal reporting as reviewed by the Chief Executive Officer.

 

In the current year the reportable segments have been revised to provide greater understanding of the Group's activities. The main change from the prior year is separating the former Health & Analysis sector into two sectors, namely the Medical and Environmental & Analysis sectors. This separation reflects the Group's growing presence in the medical devices market, in particular in ophthalmology and blood pressure monitoring. The Process Safety and Infrastructure Safety sectors, (formerly named Industrial Safety and Infrastructure Sensors respectively) are unchanged. Prior year results have been restated to reflect the revised reportable segments.



Segment revenue and results

 


Revenue (all continuing operations)


52 weeks to 

30 March 

 2013 

 £000 

(Restated)

52 weeks to 

31 March 

2012 

£000 

Process Safety

125,656 

122,240 

Infrastructure Safety

205,315 

204,280 

Medical

136,054 

100,361 

Environmental & Analysis

152,448 

153,351 

Inter-segmental sales

(263)

(349)

Revenue for the year

619,210 

579,883 

 

Inter-segmental sales are charged at prevailing market prices and have not been disclosed separately by segment as they are
not considered material. The Group does not analyse revenue by product group and has no material revenue derived from the rendering of services.

 


Profit (all continuing operations)


52 weeks to

30 March 2013

£000

(Restated)

52 weeks to

31 March

2012

£000

Segment profit before allocation of amortisation of acquired intangible assets, acquisition costs and profit on disposal of continuing operations



Process Safety

32,310

29,226

Infrastructure Safety

41,759

39,099

Medical

35,934

26,252

Environmental & Analysis

30,385

31,596


140,388

126,173

Segment profit after allocation of amortisation of acquired intangible assets, acquisition costs* and profit on disposal of continuing operations



Process Safety

39,848

28,627

Infrastructure Safety

41,705

39,276

Medical

24,146

21,058

Environmental & Analysis

26,282

28,721

Segment profit

131,981

117,682

Central administration costs

(5,896)

(4,266)

Net finance expense

(3,831)

(1,442)

Group profit before taxation

122,254

111,974

Taxation

(27,038)

(25,260)

Profit for the year

95,216

86,714

 

* Acquisition costs comprise transaction costs and adjustments to contingent consideration.

 

The accounting policies of the reportable segments are the same as the Group's accounting policies. For acquisitions after 3 April 2010, acquisition transaction costs and movement on contingent consideration are recognised in the Consolidated Income Statement. Segment profit, before these acquisition costs, the amortisation of acquired intangible assets and the profit on disposal of continuing operations is disclosed separately above as this is the measure reported to the Chief Executive Officer for the purpose of allocation of resources and assessment of segment performance.

 

The amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration (including any arising from foreign exchange revaluation) and profit on disposal of continuing operations are analysed as follows:

 







2013



Acquisition costs





Amortisation of acquired intangibles

£000

Transaction costs

£000

Adjustments to contingent consideration

£000

Total amortisation charge and acquisition costs

£000

Disposal of

continuing

operations

(note 9)

£000

Total

£000

Process Safety

(602)

-

(16)

(618)

8,156

7,538

Infrastructure Safety

-

(54)

-

(54)

-

(54)

Medical

(9,947)

(2,272)

517

(11,702)

(86)

(11,788)

Environmental & Analysis

(3,686)

(417)

-

(4,103)

-

(4,103)

Total Group

(14,235)

(2,743)

501

(16,477)

8,070

(8,407)

 

The transaction costs mainly arose on the acquisitions in Note 8 of SunTech Medical Group Limited (£948,000), MicroSurgical Technology, Inc. (£851,000), Sensorex Corporation (£298,000), Thinketron Precision Equipment Company Limited (£246,000), Accutome, Inc. (£216,000) and ASL Holdings, Limited (£119,000).

 







(Restated)

2012



Acquisition costs





Amortisation of acquired intangibles

£000

Transaction costs

£000

Adjustments to contingent consideration

£000

Total amortisation charge and acquisition costs

£000

Disposal of continuing operations

£000

Total

£000

Process Safety

(548)

(51)

-

(599)

-

(599)

Infrastructure Safety

-

-

177

177

-

177

Medical

(7,599)

(409)

(729)

(8,737)

3,543

(5,194)

Environmental & Analysis

(2,205)

(258)

(412)

(2,875)

-

(2,875)

Total Group

(10,352)

(718)

(964)

(12,034)

3,543

(8,491)

 

 

Geographical information

 

The Group's revenue from external customers (by location of customer) is detailed below:

 


Revenue by destination


2013

£000

2012

£000

United States of America

194,990

161,951

Mainland Europe

151,631

154,428

United Kingdom

115,575

125,613

Asia Pacific*

100,532

87,277

Africa, Near and Middle East

31,380

27,750

Other countries

25,102

22,864


619,210

579,883

 

*  Formerly Asia Pacific and Australasia

 

 

 

3  Finance income



 


2013 

£000 

2012 

£000 

Interest receivable

195 

212 

Expected return on pension scheme assets

8,769 

9,529 


8,964 

9,741 

Fair value movement on derivative financial instruments

- 

329 


8,964 

10,070 

 

 

 

4  Finance expense



 


2013 

£000 

2012 

£000 

Interest payable on bank loans and overdrafts

2,366 

1,383 

Amortisation of finance costs

634 

282 

Interest charge on pension scheme liabilities

9,239 

9,684 

Other interest payable

90 

107 


12,329 

11,456 

Fair value movement on derivative financial instruments

384 

-   

Unwinding of discount on provisions

82 

56 


12,795 

11,512 

 

 

 

5  Taxation



 


2013 

£000 

2012 

£000 

Current tax



UK corporation tax at 24% (2012: 26%)

8,081 

9,021 

Overseas taxation

19,046 

15,635 

Adjustments in respect of prior years

(178)

753 

Total current tax charge

26,949 

25,409 

Deferred tax



Origination and reversal of timing differences

(40)

362 

Adjustments in respect of prior years

129 

(511)

Total deferred tax charge/(credit)

89 

(149)

Total tax charge recognised in the Consolidated Income Statement

27,038 

25,260 

Reconciliation of the effective tax rate:



Profit before tax

122,254 

111,974 




Tax at the UK corporation tax rate of 24% (2012: 26%)

29,341 

29,113 

Overseas tax rate differences

5,413 

3,574 

Permanent differences

(7,667)

(7,669)

Adjustments in respect of prior years

(49)

242 


27,038 

25,260 

Effective tax rate (after amortisation of acquired intangible assets, acquisition transaction costs,
movement on contingent consideration and profit on disposal of continuing operations)

22.1% 

22.6% 

 


2013 

£000 

2012 

£000 

Profit before tax*

130,661 

120,465 

Total tax charge*

31,670 

28,256 

Effective tax rate*

24.2% 

23.5% 

 

* Before amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration and profit on disposal of continuing operations.

 

 

 

6  Earnings per ordinary share

Basic earnings per ordinary share are calculated using the weighted average of 377,597,126 shares in issue during the year (net of shares purchased by the Company and held as treasury shares) (2012: 376,926,013). Diluted earnings per ordinary share are calculated using the weighted average of 378,009,506 shares (2012: 377,473,142), which includes dilutive potential ordinary shares of 412,380 (2012: 547,129). Dilutive potential ordinary shares are calculated from those exercisable share options where the exercise price is less than the average price of the Company's ordinary shares during the year.

 

Adjusted earnings are calculated as earnings from continuing operations excluding the amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration and profit on disposal of continuing operations after tax. The Directors consider that adjusted earnings represent a more consistent measure of underlying performance. A reconciliation of earnings and the effect on basic earnings per share figures is as follows:

 




Per ordinary share


2013

£000

2012

£000

2013

pence

2012

pence

Earnings from continuing operations

95,216

86,714

25.22

23.01

Add back amortisation of acquired intangible assets (after tax)

9,978

7,561

2.64

2.00

Acquisition transaction costs (after tax)

2,252

691

0.60

0.18

Adjustments to contingent consideration (after tax)

(385)

786

(0.10)

0.21

Profit on disposal of continuing operations (after tax)

(8,070)

(3,543)

(2.14)

(0.94)

Adjusted earnings

98,991

92,209

26.22

24.46

 

 

 

7  Dividends



 


Per ordinary share




2013

pence

2012

pence

2013

£000

2012

£000

Amounts recognised as distributions to shareholders in the year





Final dividend for the year to 31 March 2012 (2 April 2011)

5.95

5.56

22,425

20,934

4.06

3.79

15,340

14,298

10.01

9.35

37,765

35,232

Dividends declared in respect of the year





Interim dividend for the year to 30 March 2013 (31 March 2012)

4.06

3.79

15,340

14,298

6.37

5.95

24,069

22,425

10.43

9.74

39,409

36,723

 

The proposed final dividend is subject to approval by shareholders at the Annual General Meeting on 25 July 2013 and has not been included as a liability in these financial statements. If approved, the final dividend for 2012/13 will be paid on 21 August 2013 to shareholders on the register at the close of business on 19 July 2013.

 

The Company offers a Dividend Reinvestment Plan ('DRIP') to enable shareholders to elect to have their cash dividends reinvested in Halma shares. Shareholders who wish to elect for the DRIP for the forthcoming final dividend, but have not already done so, should return a DRIP mandate form to the Company's Registrars no later than 31 July 2013.

 

 

 

8  Acquisitions

 

The Group made six acquisitions during the year. Below are summaries of the assets and liabilities acquired and the purchase consideration of:

 

a)   the total of all acquisitions and adjustments to prior year acquisitions;

b)   the six acquisitions, namely Sensorex Corporation, Accutome, Inc., SunTech Medical Group Limited, MicroSurgical Technology, Inc., Thinketron Precision Equipment Company Limited and ASL Holdings Limited.

c)   the one acquisition made since the balance sheet date, namely Talentum Developments Limited.

 

 

 

(A)  Total of all acquisitions and adjustments to prior year acquisitions

 


Book value

 £000

Provisional
fair value
adjustments

 £000

Total

£000

Non-current assets




Intangible assets

508

68,612

69,120

Property, plant and equipment

2,801

(22)

2,779

Current assets




Inventories

10,310

(142)

10,168

Trade and other receivables

10,435

(121)

10,314

Cash and cash equivalents

7,874

(5)

7,869

Deferred tax

212

687

899

Total assets

32,140

69,009

101,149

Current liabilities




Overdrafts

(869)

-

(869)

Trade and other payables

(7,826)

(1,154)

(8,980)

Bank loans

(1,603)

-

(1,603)

Provisions

(61)

(256)

(317)

Corporation tax

(13)

-

(13)

Non-current liabilities




Bank loans

(803)

-

(803)

Provisions

(21)

(87)

(108)

Deferred tax

-

(10,107)

(10,107)

Total liabilities

(11,196)

(11,604)

(22,800)

Net assets of businesses acquired

20,944

57,405

78,349





Initial cash consideration paid



133,060

Initial cash consideration to be paid



1,879

Contingent purchase consideration (current year acquisitions)



25,569

Total consideration



160,508





Goodwill arising on current year acquisitions



82,159

Goodwill arising on prior year acquisitions



-




82,159

 

Due to their contractual dates, the fair value of receivables acquired (shown above) approximates to the gross contractual amounts receivable. The amount of gross contractual receivables not expected to be recovered is immaterial.

 

There are no material contingent liabilities recognised in accordance with paragraph 23 of IFRS 3 (revised).

 

£68,613,000 of the goodwill arising on acquisitions in the year is expected to be deductible for tax purposes.

 

Together, the six acquisitions contributed £41,310,000 of revenue and £7,429,000 of profit after tax for the period ended 30 March 2013. If these acquisitions had been held since the start of the financial year, it is estimated the Group's reported revenue and profit after tax would have been £24,860,000 and £4,324,000 higher respectively.

 

Adjustments were made to the book values of the net assets of the companies acquired to reflect their provisional fair values to the Group. Acquired inventories were valued at the lower of cost and net realisable value adopting Group bases and any liabilities for warranties relating to past trading were recognised. Other previously unrecognised assets and liabilities at acquisition were included and accounting policies were aligned with those of the Group where appropriate.

 

There were no adjustments to prior year acquisitions.

 

Analysis of cash outflow in the Consolidated Cash Flow Statement




2013

£000

2012

£000

Cash consideration in respect of acquisitions

133,060

13,305

Cash acquired on acquisitions

(7,869)

(49)

Overdrafts acquired on acquisitions

869

-

Contingent consideration paid in relation to current year acquisitions

3,810

-

Contingent consideration paid in relation to prior year acquisitions*

15,771

5,411

Net cash outflow relating to acquisitions (per cash flow statement)

145,641

18,667

Bank loans acquired

2,406

1,144

Net movement in cash and debt, including bank loans acquired

148,047

19,811

 

* Of the £15,771,000 (2012: £5,411,000) contingent purchase consideration payment £15,771,000 (2012: £5,411,000) had been provided in the prior year's financial statements.

 

 

 

(Bi)  Sensorex Corporation 




 


Book value

£000

Provisional
 fair value
 adjustments

£000

Total

£000

Non-current assets




Intangible assets

-

12,689

12,689

Property, plant and equipment

286

-

286

Current assets




Inventories

564

(80)

484

Trade and other receivables

1,176

1

1,177

Total assets

2,026

12,610

14,636

Current liabilities




Trade and other payables

(268)

(56)

(324)

Provisions

-

(45)

(45)

Non-current liabilities




Deferred tax

-

(290)

(290)

Total liabilities

(268)

(391)

(659)

Net assets of businesses acquired

1,758

12,219

13,977





Cash consideration



23,716

Contingent purchase consideration



-

Total consideration



23,716





Goodwill arising on acquisition



9,739

 

On 2 April 2012, the Group acquired the trade and assets of Sensorex Corporation (Sensorex) for US$38,003,000. Sensorex, based in California, USA, manufactures electrochemical sensors for water analysis applications.

 

Sensorex forms part of the Environmental & Analysis sector and was acquired for its range of sensors and associated accessories, which are incorporated by OEMs manufacturing single and multi-parameter probes and instruments for monitoring water quality, a market that is forecast to see continued growth. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by customer-related intangibles of £9,998,000 and technological know-how intangibles of £2,691,000 with residual goodwill arising of £9,739,000. The goodwill represents:

 

a)    the value of the acquired workforce;

b)    potential synergies with other Halma companies within the Water market, especially the hubs in China and India; and

c)    the ability to exploit the Group's existing distribution arrangements, particularly outside the USA.

There are no contingent consideration payment arrangements.

The Sensorex acquisition contributed £7,781,000 of revenue and £2,466,000 of profit after tax for the year ended 30 March 2013.

 

 

(Bii)  Accutome, Inc.




 


Book value

£000

Provisional
fair value
adjustments

£000

Total

 £000

Non-current assets




Intangible assets

20

6,144

6,164

Property, plant and equipment

683

(39)

644

Current assets




Inventories

2,768

111

2,879

Trade and other receivables

1,800

(518)

1,282

Deferred tax

-

342

342

Total assets

5,271

6,040

11,311

Current liabilities




Overdrafts

(116)

-

(116)

Trade and other payables

(1,418)

(391)

(1,809)

Bank loans

(1,307)

-

(1,307)

Provisions

-

(143)

(143)

Non-current liabilities




Bank loans

(131)

-

(131)

Provisions

-

(25)

(25)

Deferred tax

-

(2,342)

(2,342)

Total liabilities

(2,972)

(2,901)

(5,873)

Net assets of businesses acquired

2,299

3,139

5,438





Cash consideration



11,230

Contingent purchase consideration



3,120

Total consideration



14,350





Goodwill arising on acquisition



8,912

 

On 2 April 2012, the Group acquired 100% of the issued share capital of Accutome, Inc. (Accutome) for US$17,995,000 (US$20,298,000 including repayment of US$2,303,000 bank loans). Accutome, based in Pennsylvania, USA, with a wholly owned subsidiary located in the Netherlands, designs, manufactures and sells surgical and diagnostic instruments and a variety of pharmaceuticals for the ophthalmic marketplace.

 

Accutome is best known for its leading ultrasound diagnostic equipment (used prior to cataract surgery and to diagnose certain eye conditions) and for its surgical instrumentation, featuring its leading diamond bladed surgical knives. Accutome forms part of the Medical sector and was acquired to further expand Halma's footprint in ophthalmic diagnostic and surgical instrumentation. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by supplier arrangement intangibles of £2,102,000, customer-related intangibles of £2,861,000 and brand intangibles of £1,201,000 with residual goodwill arising of £8,912,000. The goodwill represents:

 

a)   the value of the acquired workforce;

b)   the ability to exploit Accutome's distribution arrangements;

c)    potential synergies with other Halma companies within the ophthalmic market; and

d)   the ability to exploit the Group's existing distribution arrangements, particularly outside North America.

 

Contingent consideration of between US$nil and US$5,000,000 is payable dependent on the profits of the acquired business for the period up to September 2013. The Directors' initial estimate that contingent consideration of US$5,000,000 will be paid, remains unchanged as at 30 March 2013.

 

The Accutome acquisition contributed £13,420,000 of revenue and £1,444,000 of profit after tax for the year ended 30 March 2013.

 

 

(Biii)  SunTech Medical Group Limited

 


Book value

£000

Provisional
fair value
adjustments

£000

Total

 £000

Non-current assets




Intangible assets

9

12,586

12,595

Property, plant and equipment

672

(1)

671

Current assets




Inventories

4,047

(276)

3,771

Trade and other receivables

3,146

604

3,750

Cash and cash equivalents

3,641

(5)

3,636

Deferred tax

212

323

535

Total assets

11,727

13,231

24,958

Current liabilities




Trade and other payables

(1,540)

(153)

(1,693)

Provisions

(51)

(37)

(88)

Non-current liabilities




Provisions

(21)

-

(21)

Deferred tax

-

(4,783)

(4,783)

Total liabilities

(1,612)

(4,973)

(6,585)

Net assets of businesses acquired

10,115

8,258

18,373





Initial cash consideration paid



31,975

Initial cash consideration to be paid



1,811

Contingent purchase consideration



3,857

Total consideration



37,643





Goodwill arising on acquisition



19,270

 

On 31 May 2012 the Group acquired 100% of the issued share capital of the SunTech Medical Group Limited (SunTech), which is primarily based in the USA, UK and China. The initial cash consideration of US$51,000,000 was adjustable based on the final level of agreed working capital, which was later determined to be $1,556,000.

 

The initial cash consideration to be paid of £1,811,000 in the above table was paid in full on 10 May 2013. This amount was included in Group cash and liabilities at the balance sheet date.

 

SunTech forms part of the Medical sector and is a pre-eminent supplier of clinical grade non-invasive blood pressure monitoring products and technologies. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by customer-related intangibles of £6,103,000, technological know-how intangibles of £3,641,000 and brand intangibles of £2,842,000 with residual goodwill arising of £19,270,000. The goodwill represents:

 

a)    the value of the acquired workforce; and

b)    potential synergies with other Halma companies within the blood pressure monitoring market.

 

Contingent consideration of between US$nil and US$6,000,000 was payable dependent on the profits of the acquired business for the 12 months to December 2012. On 30 January 2013 the Directors' estimate of US$6,000,000 (£3,810,000 at the prevailing exchange rate) was paid in full.

 

The SunTech acquisition contributed £14,731,000 of revenue and £2,570,000 of profit after tax for the year ended 30 March 2013.

 

 

(Biv)   MicroSurgical Technology, Inc.

 


Book value

£000

Provisional
fair value
adjustments

£000

Total

 £000

Non-current assets




Intangible assets

193

22,820

23,013

Property, plant and equipment

910

17

927

Current assets




Inventories

1,223

401

1,624

Trade and other receivables

1,860

(56)

1,804

Cash and cash equivalents

1,303

-

1,303

Total assets

5,489

23,182

28,671

Current liabilities




Trade and other payables

(1,174)

(155)

(1,329)

Bank loans

(296)

-

(296)

Provisions

(10)

(29)

(39)

Non-current liabilities




Bank loans

(672)

-

(672)

Provisions

-

(62)

(62)

Deferred tax

-

-

-

Total liabilities

(2,152)

(246)

(2,398)

Net assets of businesses acquired

3,337

22,936

26,273





Initial cash consideration paid



35,454

Initial cash consideration to be paid



68

Contingent purchase consideration



15,092

Total consideration



50,614





Goodwill arising on acquisition



24,341

 

On 18 December 2012, the Group acquired 100% of the issued share capital of MicroSurgical Technology, Inc. (MST). MST, based in Redmond, USA, designs, manufactures and markets ophthalmic surgical products, focusing on single-use devices used in cataract surgery. MST forms part of the Medical sector and was acquired to give Halma's Medical businesses access to additional technologies and manufacturing processes. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by customer related intangibles of £15,570,000, brand intangibles of £2,090,000 and technological know-how intangibles of £5,335,000 with residual goodwill arising of £24,341,000. The goodwill represents:

 

a)   the engineering expertise of the acquired workforce;

b)   the opportunity to leverage this expertise across all Halma's Medical businesses; and

c)    the ability to exploit the Group's existing customer base.

 

The initial consideration was US$57,430,000 (US$59,000,000 including repayment of US$1,570,000 bank loans), followed by contingent consideration payable on or around May 2014 and May 2015 of between US$nil and US$25,000,000 in the first year and US$nil and US$30,000,000 in the second year, dependent on the profits of the acquired business for the period up to March 2014 and March 2015 respectively. The total contingent consideration payable for both years is subject to a cap of US$43,000,000. The Directors' best estimate of the likely overall payment is US$25,000,000 and this amount has been included at fair value in the summary above.

 

Initial cash consideration to be paid relates to a working capital adjustment of £68,000 (US$110,000) based on the closing net assets of the acquired business.

 

The MST acquisition contributed £4,167,000 of revenue and £696,000 of profit after tax for the year ended 30 March 2013.

 

 

(Bv) Thinketron Precision Equipment Company Limited (and its main trading subsidiary, Baoding Longer Precision Pump Co., Ltd)

 


Book value

£000

Provisional
fair value
adjustments

£000

Total

 £000

Non-current assets




Intangible assets

-

8,432

8,432

Property, plant and equipment

216

(10)

206

Current assets




Inventories

861

(71)

790

Trade and other receivables

651

(52)

599

Cash and cash equivalents

2,295

-

2,295

Deferred tax

-

22

22

Total assets

4,023

8,321

12,344

Current liabilities




Trade and other payables

(574)

(21)

(595)

Provisions

-

(2)

(2)

Corporation tax

(13)

-

(13)

Non-current liabilities




Deferred tax

-

(1,265)

(1,265)

Total liabilities

(587)

(1,288)

(1,875)

Net assets of businesses acquired

3,436

7,033

10,469





Cash consideration



24,320

Contingent purchase consideration



-

Total consideration



24,320





Goodwill arising on acquisition



13,851

 

On 23 January 2013, the Group acquired 100% of the issued share capital of the holding company, Thinketron Precision Equipment Company Limited, and its subsidiaries Baoding Longer Precision Pump Co., Ltd. and Langer Instruments Corporation, (Longer Pump, collectively). Longer Pump, based primarily in Baoding, China, manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. Longer Pump forms part of the Medical sector and was acquired to give Halma's businesses in this sector access to local market knowledge and technical resources. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by customer related intangibles of £5,554,000, brand intangibles of £1,620,000, technological know-how intangibles of £1,258,000 with residual goodwill arising of £13,851,000. The goodwill represents:

 

a)   the engineering expertise of the acquired workforce;

b)   the opportunity to leverage this expertise across all of Halma's Medical businesses; and

c)    the ability to exploit the Group's existing customer base through increased access to, and presence in, a dynamic

       region.

The initial consideration was RMB 241,954,000 with no further consideration payable.

 

The Longer Pump acquisition contributed £915,000 of revenue and £270,000 of profit after tax for the year ended 30 March 2013.

 

 

(Bvi)  ASL Holdings Limited

 

 


Book value 

£000 

Provisional 

Fair value  adjustments 

£000 

Total 

 £000 

Non-current assets




Intangible assets

286 

5,941 

6,227 

Property, plant and equipment

34 

11 

45 

Current assets




Inventories

847 

(227)

620 

Trade and other receivables

1,802 

(100)

1,702 

Cash and cash equivalents

635 

- 

635 

Total assets

3,604 

5,625 

9,229 

Current liabilities




Overdrafts

(753)

- 

(753)

Trade and other payables

(2,852)

(378)

(3,230)

Non-current liabilities




Deferred tax

- 

(1,427)

(1,427)

Total liabilities

(3,605)

(1,805)

(5,410)

Net assets of businesses acquired

(1)

3,820 

3,819 





Cash consideration



6,365 

Contingent purchase consideration



3,500 

Total consideration



9,865 





Goodwill arising on acquisition



6,046 

 

 

On 14 March 2013, the Group acquired 100% of the issued share capital of ASL Holdings Limited (ASL). ASL, based in Northampton, UK, designs and manufactures machine-to-machine (M2M) communication products which are incorporated into SMART meters for remote data monitoring and a range of other applications in the utility, transport and retail sectors. ASL forms part of the Environmental & Analysis sector and was acquired to compliment and strengthen Halma's existing Environmental & Analysis businesses. The excess of the fair value of the consideration paid over the fair value of the assets acquired is represented by customer related intangibles of £6,204,000 with residual goodwill arising of £6,046,000. The goodwill represents:

 

a)   the technical expertise of the acquired workforce;

b)   the opportunity to leverage this expertise across some of Halma's businesses; and

c)   the ability to exploit the Group's existing customer base.

 

The initial consideration was £6,365,000, followed by contingent consideration payable in two tranches on or around May 2014 and May 2015 of between £nil and £2,000,000, and £nil and £1,500,000 respectively, dependent on the sales growth of the acquired business for the years ending March 2014 and March 2015. The fair value of contingent consideration at the balance sheet date is based on the assumption that the full value will be payable at the end of each year, which represents the Directors' best estimate of the likely outcome taking into account the proximity of the acquisition to the year end.

 

The ASL acquisition contributed £296,000 of revenue and £17,000 of loss after tax for the year ended 30 March 2013.

 

 

Since the balance sheet, the Group has made one further acquisition.

 

(C)  Talentum Developments Limited

Due to the proximity of the acquisition dates to the date of approval of the Annual Report, it is only practicable to provide provisional summaries of the details of one acquisition made since the balance sheet date.

 

On 11 April 2013 the Group acquired Talentum Developments Limited (Talentum). The initial cash consideration of £2,590,000 for the share capital is adjustable based on the final level of agreed working capital and cash at closing. Deferred consideration of £250,000 is payable on or around April 2014 subject to the seller providing certain pre-agreed technical information and know-how to the Group. Talentum forms part of the Infrastructure Safety sector and specialises in the design and manufacture of flame detector products for a range of industries, which protect property from the risk of fire. Due to the proximity of the acquisition date to the date of approval of the Annual Report, it is impracticable to provide further information.

 

 

 

9  Disposal of business

 

On 22 August 2012, the Group disposed of two businesses within its Process Safety sector, Tritech Holdings Limited and its subsidiary Tritech International Limited (together known as "Tritech"), for an initial cash consideration of £18,900,000. A further £839,000 was received in October 2012 in respect of cash and working capital held in the business at the time of sale. In addition, £2,100,000 is retained in escrow and will be released to Halma on the anniversary of the transaction subject to any valid warranty/indemnity claims being made by the purchaser. The Directors estimate that the entire £2,100,000 will be received. The profit on disposal is estimated to be £8,070,000, being the total £21,839,000 consideration above less £1,435,000 of transaction costs (of which £86,000 related to a prior year disposal), £8,009,000 of goodwill and £4,325,000 of net assets.

 

The cash inflow in the Consolidated Cash Flow Statement of £19,608,000 comprises £19,739,000 initial consideration for Tritech and £1,500,000 released from escrow for the prior year disposal of Volumatic Limited less £1,435,000 of transaction costs and £196,000 cash held by the disposed business. The profit on disposal of £3,543,000 million and cash inflow of £3,554,000 in the 52 weeks to 31 March 2012 related entirely to the disposal of Volumatic Limited on 30 March 2012.

 

Tritech and Volumatic Limited have not been separately disclosed as discontinued operations as defined by IFRS 5 due to their nature and size.

 

 

 

10  Notes to the Consolidated Cash Flow Statement



 


2013

£000

2012

£000

Reconciliation of profit from operations to net cash inflow from operating activities:



Profit on continuing operations before finance income and expense, share of results of associates and



profit on disposal of continuing operations

118,367

109,910

Depreciation of property, plant and equipment

12,684

12,178

Amortisation of computer software

1,402

1,319

Amortisation of capitalised development costs and other intangibles

3,578

3,820

Disposals/retirements of capitalised development costs

264

-

Amortisation of acquired intangible assets

14,235

10,352

Share-based payment expense in excess of amounts paid

2,482

2,432

Additional payments to pension plans

(8,265)

(6,419)

Profit on sale of property, plant and equipment and computer software

(163)

(495)

Operating cash flows before movement in working capital

144,584

133,097

Increase in inventories

(2,693)

(3,777)

Increase in receivables

(9,210)

(1,190)

Increase/(decrease) in payables and provisions

1,015

(2,671)

Cash generated from operations

133,696

125,459

Taxation paid

(25,452)

(27,772)

Net cash inflow from operating activities

108,244

97,687

 


2013

£000

2012

£000

Analysis of cash and cash equivalents



Cash and bank balances

49,723

45,305

 


At 1 April

2012

£000

Cash flow

£000

Net cash/

(debt)

acquired

£000

Loan

notes

Issued

£000

Exchange

 adjustments

£000

At 30 March

2013

£000

Analysis of net debt







Cash and cash equivalents

45,305

(3,815)

7,000

-

1,233

49,723

Loan notes falling due within one year

-

-

-

(2,515)

-

(2,515)

Bank loans falling due within one year

-

(929)

(1,603)

-

(100)

(2,632)

Bank loans falling due after more than one year

(64,014)

(88,427)

 (803)

-

(1,622)

(154,866)

Total net debt

(18,709)

(93,171)

4,594

(2,515)

(489)

(110,290)

 

The net cash outflow from bank loans in 2013 comprised drawdowns of £92,298,000 offset by repayments of £2,942,000
(2012: net cash inflow comprising drawdowns of £76,456,000 offset by repayments of £94,050,000).

 

The £7,000,000 cash and cash equivalents acquired comprised £7,869,000 cash and bank balances less £869,000 overdrafts.

 

 

 

11  Non-GAAP measures

 

The Board uses certain non-GAAP measures to help it effectively monitor the performance of the Group. These measures include Return on Capital Employed, Return on Total Invested Capital, Organic growth, Adjusted operating profit and Adjusted operating cash flow.

 

Return on Capital Employed

 

 

 


2013

£000

2012

£000

Operating profit before amortisation of acquired intangible assets, acquisition
transaction costs and movement on contingent consideration, but after share
of results of associates

134,492

121,907

Computer software costs within intangible assets

2,383

2,678

Capitalised development costs within intangible assets

11,977

10,508

Other intangibles within intangible assets

146

215

Property, plant and equipment

76,725

72,118

Inventories

69,713

57,368

Trade and other receivables

133,605

114,674

Trade and other payables

(100,929)

(93,499)

Provisions

(2,420)

(2,618)

Net tax liabilities

(11,262)

(11,582)

Non-current trade and other payables

(22,649)

(13,388)

Non-current provisions

(2,100)

(2,301)

Add back contingent purchase consideration

33,512

29,110

Capital employed

188,701

163,283

Return on Capital Employed

71.3%

74.7%

 

 

Return on Total Invested Capital



 


2013

£000

2012

£000

Post-tax profit before amortisation of acquired intangible assets, acquisition
transaction costs, movement on contingent consideration and profit on disposal
of continuing operations

98,991

92,209

Total shareholders' funds

453,267

398,112

Add back retirement benefit obligations

47,172

32,997

Less associated deferred tax assets

(10,851)

(7,920)

Cumulative amortisation of acquired intangibles

46,150

36,306

Historic adjustments to goodwill*

89,549

89,549

Total invested capital

625,287

549,044

Return on Total Invested Capital

15.8 %

16.8%

 

* Includes goodwill amortised prior to 3 April 2004 and goodwill taken to reserves.

 

Organic growth

Organic growth measures the change in revenue and profit from continuing Group operations. The effect of acquisitions and disposals made during the prior financial year, and acquisitions made in the current financial year has been equalised by adjusting the current year results for a pro-rated contributions based on their revenues and profits before taxation at the dates of acquisition and disposal. The results of disposals made in the prior financial year have been removed from the prior year reported revenue and profit before taxation. Organic growth has been calculated as follows:

 


Revenue

Profit* before taxation


2013

£000

2012

£000

%

 growth

2013

£000

2012

£000

%

growth

Continuing operations

619,210

579,883


130,661

120,465


Acquired revenue/profit

(37,941)

(11,394)


(6,933)

(1,633)



581,269

568,489

2.2%

123,728

118,832

4.1%

 

 * Before amortisation of acquired intangible assets, acquisition transaction costs, movement on contingent consideration and profit on disposal of continuing operations.

 

 

Adjusted operating profit

 


2013

£000

2012

£000

Operating profit

118,367

109,910

Add back:



Acquisition costs and contingent consideration fair value adjustments

2,242

1,682

Amortisation of acquisition-related intangible assets

14,235

10,352

Adjusted operating profit

134,844

121,944

 

Adjusted operating cash flow

 


2013

£000

2012

£000

Net cash from operating activities (note 10)

108,244

97,687

Add back:



Taxes paid

25,452

27,772

Proceeds from sale of property, plant and equipment

917

1,244

Less:



Purchase of property, plant and equipment

(14,472)

(15,196)

Purchase of computer software and other intangibles

(1,053)

(1,339)

Development costs capitalised

(5,443)

(4,718)

Adjusted operating cash flow

113,645

105,450

Cash conversion % (adjusted operating cash flow/adjusted operating profit)

84%

86%

 

 

 

12  Events after the balance sheet date

On 11 April 2013 the Group acquired Talentum Developments Limited (Talentum). The initial cash consideration of £2,590,000 for the share capital is adjustable based on the final level of agreed working capital and cash at closing. Contingent consideration of £250,000 is payable on or around April 2014 subject to the seller providing certain pre-agreed technical information and know-how to the Group. Talentum forms part of the Infrastructure Safety sector and specialises in the design and manufacture of flame detector products for a range of industries, which protect property from the risk of fire. Due to the proximity of the acquisition date to the date of approval of the Annual Report, it is impracticable to provide further information.

 

 

 

13  Related party transactions

 

Trading transactions

 


2013

£000

2012

£000

Associated companies



Purchases from associated companies

519

860

Amounts due to associated companies

3

98

Amounts due from associated companies

200

302




Other related parties



Rent charged by other related parties

360

365

Amounts due to other related parties

-

20

 

Other related parties comprise two companies with Halma employees on the Boards and from which two Halma subsidiaries rent property. All the transactions above are on an arm's length basis and on standard business terms.

 

Remuneration of key management personnel

The remuneration of the Directors and Divisional Chief Executives, who are the key management personnel of the Group, is set out below in aggregate for each of the categories specified in IAS 24 Related Party Disclosures. Further information about the remuneration of individual Directors is provided in the audited part of the Directors' Remuneration Report in the Annual Report and Accounts 2013.

 


2013

£000

2012

£000

Wages and salaries

4,185

4,342 

Pension costs

165

173 

Shared-based payment charge

1,643

1,532 


5,993

6,047 

 

 

 

Cautionary note

This Preliminary Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement.  Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future.  Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR NKBDQPBKDFAD